{
  "meta": {
    "id": "test11",
    "title": "Mid Day Module (Biochemistry-2) - 2024-12-24",
    "category": "Subject Wise / Mixed"
  },
  "questions": [
    {
      "text": "Which of the following color reactions is most likely used to confirm the presence of tyrosine in the protein?",
      "options": [
        {
          "label": "A",
          "text": "Aldehyde test",
          "correct": false
        },
        {
          "label": "B",
          "text": "Millon\u2019s test",
          "correct": true
        },
        {
          "label": "C",
          "text": "Ninhydrin test",
          "correct": false
        },
        {
          "label": "D",
          "text": "Biuret test",
          "correct": false
        }
      ],
      "correct_answer": "B. Millon\u2019s test",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/18/picture6.jpg"
      ],
      "explanation": "<p><strong>Ans. B)</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The phenol group of phenylalanine and tyrosine containing proteins, when heated with mercuric sulfate in sulphuric acid and sodium nitrite form red coloured mercury phenolate.</li><li>\u27a4 The phenol group of phenylalanine and tyrosine containing proteins, when heated with mercuric sulfate in sulphuric acid and sodium nitrite form red coloured mercury phenolate.</li><li>\u27a4 phenylalanine and tyrosine</li><li>\u27a4 heated with mercuric sulfate</li><li>\u27a4 sulphuric acid and sodium nitrite</li><li>\u27a4 red coloured mercury phenolate.</li><li>\u27a4 Done by Millon, 1812\u20131867. Chloride interferes with this reaction</li><li>\u27a4 Done by Millon, 1812\u20131867.</li><li>\u27a4 Millon, 1812\u20131867.</li><li>\u27a4 Chloride interferes with this reaction</li><li>\u27a4 Chloride</li><li>\u27a4 reaction</li><li>\u27a4 Ref : Vasudevan 9/e p 31.</li><li>\u27a4 Ref</li><li>\u27a4 : Vasudevan 9/e p 31.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "40a6b9d4",
      "audio": ""
    },
    {
      "text": "Which of the following statements about the isoelectric pH (pI) of a molecule is INCORRECT?",
      "options": [
        {
          "label": "A",
          "text": "The molecule carries no net charge",
          "correct": false
        },
        {
          "label": "B",
          "text": "Solubility and buffering capacity will be maximum",
          "correct": true
        },
        {
          "label": "C",
          "text": "The buffering capacity of plasma proteins are mainly due to Histidine residue.",
          "correct": false
        },
        {
          "label": "D",
          "text": "There is no mobility in an electric field",
          "correct": false
        }
      ],
      "correct_answer": "B. Solubility and buffering capacity will be maximum",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Solubility and buffering capacity will be maximum</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: The molecule carries no net charge - This is correct . At the isoelectric point, the number of positive charges equals the number of negative charges , resulting in no net charge .</li><li>\u2022 Option A: The molecule carries no net charge -</li><li>\u2022 correct</li><li>\u2022 isoelectric</li><li>\u2022 positive charges equals</li><li>\u2022 negative charges</li><li>\u2022 no net charge</li><li>\u2022 Option C: The buffering capacity of plasma proteins is mainly due to Histidine residue - This statement is generally correct as histidine residues in proteins, such as those in plasma proteins , play a significant role in buffering due to the pKa of the histidine side chain being close to physiological pH.</li><li>\u2022 Option C: The buffering capacity of plasma proteins is mainly due to Histidine residue -</li><li>\u2022 correct</li><li>\u2022 histidine</li><li>\u2022 proteins,</li><li>\u2022 plasma proteins</li><li>\u2022 buffering</li><li>\u2022 pKa of the histidine side chain</li><li>\u2022 physiological pH.</li><li>\u2022 Option D: There is no mobility in an electric field - This is correct. Since the molecule has no net charge at its isoelectric point , it will not move towards either electrode in an electric field .</li><li>\u2022 Option D: There is no mobility in an electric field -</li><li>\u2022 correct.</li><li>\u2022 no net charge</li><li>\u2022 isoelectric point</li><li>\u2022 not</li><li>\u2022 either electrode</li><li>\u2022 electric field</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The pH at which the molecule carries no net charge is called an isoelectric point or isoelectric pH (pI). At an isoelectric point , the amino acid will carry no net charge, all the groups are ionized but the charges will cancel each other. Hence, at isoelectric point, there is no mobility in an electrical field. Solubility and buffering capacity will be minimum at isoelectric pH. The buffering capacity of plasma proteins and hemoglobin is mainly due to histidine residue.</li><li>\u27a4 The pH at which the molecule carries no net charge is called an isoelectric point or isoelectric pH (pI).</li><li>\u27a4 pH</li><li>\u27a4 no net charge</li><li>\u27a4 isoelectric point or isoelectric pH (pI).</li><li>\u27a4 At an isoelectric point , the amino acid will carry no net charge, all the groups are ionized but the charges will cancel each other. Hence, at isoelectric point, there is no mobility in an electrical field.</li><li>\u27a4 isoelectric point</li><li>\u27a4 amino acid</li><li>\u27a4 carry no net charge,</li><li>\u27a4 ionized</li><li>\u27a4 at isoelectric point,</li><li>\u27a4 no mobility in an electrical field.</li><li>\u27a4 Solubility and buffering capacity will be minimum at isoelectric pH.</li><li>\u27a4 Solubility and buffering capacity</li><li>\u27a4 minimum</li><li>\u27a4 isoelectric pH.</li><li>\u27a4 The buffering capacity of plasma proteins and hemoglobin is mainly due to histidine residue.</li><li>\u27a4 buffering capacity</li><li>\u27a4 plasma proteins and hemoglobin</li><li>\u27a4 histidine residue.</li><li>\u27a4 Ref : Harper 30/e: p 20.</li><li>\u27a4 Ref : Harper 30/e: p 20.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b1aaa083",
      "audio": ""
    },
    {
      "text": "A researcher is analyzing the titration curve of a nonpolar amino acid as shown in the graph with points labeled A to D. Which of the following statements correctly interprets the designated regions on the curve?",
      "options": [
        {
          "label": "A",
          "text": "Point A represents the region where the amino acid is deprotonated.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Point B represents a region of minimal buffering.",
          "correct": false
        },
        {
          "label": "C",
          "text": "Point C represents the region where the net charge on the amino acid is zero.",
          "correct": true
        },
        {
          "label": "D",
          "text": "Point D represents the pKa of the amino acid carboxyl group.",
          "correct": false
        }
      ],
      "correct_answer": "C. Point C represents the region where the net charge on the amino acid is zero.",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/18/picture9.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: Point A represents the region where the amino acid is deprotonated: The amino acid is fully protonated at Point A due to low pH and abundance of protons in the solvent.</li><li>\u2022 Option A:</li><li>\u2022 Point A represents the region where the amino acid is deprotonated:</li><li>\u2022 amino acid</li><li>\u2022 fully protonated</li><li>\u2022 Point A</li><li>\u2022 low pH</li><li>\u2022 abundance of protons</li><li>\u2022 Option B: Point B represents a region of minimal buffering & Option D Point D represents the pK of the amino acid carboxyl group: Point B represents a region of maximum buffering , as does Point D which is the pKa of amino group.</li><li>\u2022 Option B:</li><li>\u2022 Point B represents a region of minimal buffering & Option D Point D represents the pK of the amino acid carboxyl group:</li><li>\u2022 Point B</li><li>\u2022 maximum buffering</li><li>\u2022 Point D</li><li>\u2022 pKa of amino group.</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 The amino acid could be lysine . C represents the isoelectric point , or pI, and as such is midway between pK1 and pK2 for a nonpolar amino acid . Lysine is a basic amino acid and has an ionizable side chain .</li><li>\u2022 The amino acid could be lysine . C represents the isoelectric point , or pI, and as such is midway between pK1 and pK2 for a nonpolar amino acid .</li><li>\u2022 amino acid</li><li>\u2022 lysine</li><li>\u2022 C represents the isoelectric point</li><li>\u2022 pI,</li><li>\u2022 pK1 and pK2 for a nonpolar amino acid</li><li>\u2022 Lysine is a basic amino acid and has an ionizable side chain .</li><li>\u2022 Lysine</li><li>\u2022 basic amino acid</li><li>\u2022 ionizable side chain</li><li>\u2022 Ref : Lippincott 7/e: p 6-9.</li><li>\u2022 Ref : Lippincott 7/e: p 6-9.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e5b0b3ae",
      "audio": ""
    },
    {
      "text": "A patient has a point mutation at a specific site which results in disruption of the \u03b1-helical structure in a segment of the resultant mutant protein. The most likely change that can occur in the primary structure of the mutant protein is:",
      "options": [
        {
          "label": "A",
          "text": "Glutamate to aspartate",
          "correct": false
        },
        {
          "label": "B",
          "text": "Lysine to arginine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Methionine to proline",
          "correct": true
        },
        {
          "label": "D",
          "text": "Valine to alanine",
          "correct": false
        }
      ],
      "correct_answer": "C. Methionine to proline",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C)</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Proline is known as a helix breaker because its cyclic structure creates a fixed kink that can disrupt the \u03b1-helix's regular geometry . A substitution of methionine to proline in a protein's primary structure is likely to disrupt an \u03b1-helical segment .</li><li>\u27a4 Proline</li><li>\u27a4 helix breaker</li><li>\u27a4 cyclic structure</li><li>\u27a4 fixed kink</li><li>\u27a4 disrupt the \u03b1-helix's</li><li>\u27a4 geometry</li><li>\u27a4 methionine to proline</li><li>\u27a4 primary structure</li><li>\u27a4 disrupt an \u03b1-helical segment</li><li>\u27a4 Ref : Harper 30/e: p 38.</li><li>\u27a4 Ref : Harper 30/e: p 38.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d1ff870e",
      "audio": ""
    },
    {
      "text": "A biochemist is optimizing a protein assay by enhancing the protein's absorbance at 280 nm for better detection and quantification. The protein contains alanine, which does not contribute significantly to absorbance at this wavelength. The scientist is considering substituting alanine with another amino acid that naturally exhibits strong absorbance at 280 nm, which would increase the overall absorbance of the protein at this wavelength. Replacing alanine with which amino acid will increase the protein's absorbance at 280 nm?",
      "options": [
        {
          "label": "A",
          "text": "Tryptophan",
          "correct": true
        },
        {
          "label": "B",
          "text": "Arginine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Guanine",
          "correct": false
        },
        {
          "label": "D",
          "text": "Lysine",
          "correct": false
        }
      ],
      "correct_answer": "A. Tryptophan",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A)</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Amino Acids which absorb 250\u2013290 nm ( Maximum at 280 nm ) UV light are tryptophan, phenylalanine, and tyrosine . Maximum absorption of UV light is by Tryptophan.</li><li>\u27a4 Amino Acids which absorb 250\u2013290 nm ( Maximum at 280 nm ) UV light are tryptophan, phenylalanine, and tyrosine .</li><li>\u27a4 Amino Acids</li><li>\u27a4 absorb 250\u2013290 nm</li><li>\u27a4 Maximum at 280 nm</li><li>\u27a4 UV</li><li>\u27a4 tryptophan, phenylalanine, and tyrosine</li><li>\u27a4 Maximum absorption of UV light is by Tryptophan.</li><li>\u27a4 Maximum absorption</li><li>\u27a4 UV light</li><li>\u27a4 Tryptophan.</li><li>\u27a4 Ref : Harper 30/e p 21, 22.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e p 21, 22.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "76121c72",
      "audio": ""
    },
    {
      "text": "Which amino acid can be converted into an intermediate that plays a role in both the citric acid cycle and the urea cycle?",
      "options": [
        {
          "label": "A",
          "text": "Tyrosine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Lysine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Leucine",
          "correct": false
        },
        {
          "label": "D",
          "text": "Aspartate",
          "correct": true
        }
      ],
      "correct_answer": "D. Aspartate",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D)</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Aspartate can be converted to oxaloacetate , which is an intermediate in the citric acid cycle . Furthermore, aspartate is involved in the urea cycle , where it donates an amino group for the synthesis of arginine , which is then cleaved to form urea and ornithine. This connection highlights aspartate's role in both energy production and nitrogen disposal .</li><li>\u27a4 Aspartate</li><li>\u27a4 converted to oxaloacetate</li><li>\u27a4 intermediate</li><li>\u27a4 citric acid cycle</li><li>\u27a4 urea cycle</li><li>\u27a4 donates an amino group</li><li>\u27a4 synthesis of arginine</li><li>\u27a4 cleaved</li><li>\u27a4 urea and ornithine.</li><li>\u27a4 aspartate's</li><li>\u27a4 both energy production</li><li>\u27a4 nitrogen disposal</li><li>\u27a4 Ref : Vasudevan 9/e p 203, 247.</li><li>\u27a4 Ref</li><li>\u27a4 : Vasudevan 9/e p 203, 247.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ef758c88",
      "audio": ""
    },
    {
      "text": "Which enzyme is known to contain the amino acid selenocysteine?",
      "options": [
        {
          "label": "A",
          "text": "Glutathione reductase",
          "correct": false
        },
        {
          "label": "B",
          "text": "Glutathione peroxidase",
          "correct": true
        },
        {
          "label": "C",
          "text": "Thioredoxin peroxidase",
          "correct": false
        },
        {
          "label": "D",
          "text": "Thioredoxin oxidase",
          "correct": false
        }
      ],
      "correct_answer": "B. Glutathione peroxidase",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A: Glutathione reductase - This enzyme does not contain selenocysteine ; it catalyzes the reduction of glutathione disulfide to the sulfhydryl form glutathione.</li><li>\u2022 Option A: Glutathione reductase</li><li>\u2022 does not</li><li>\u2022 selenocysteine</li><li>\u2022 reduction</li><li>\u2022 glutathione disulfide</li><li>\u2022 sulfhydryl form glutathione.</li><li>\u2022 Option C: Thioredoxin peroxidase - Also known as peroxiredoxins, these do not typically contain selenocysteine.</li><li>\u2022 Option C: Thioredoxin peroxidase</li><li>\u2022 Also</li><li>\u2022 peroxiredoxins,</li><li>\u2022 do not</li><li>\u2022 selenocysteine.</li><li>\u2022 Option D: Thioredoxin oxidase - This is not a commonly recognized enzyme with selenocysteine .</li><li>\u2022 Option D: Thioredoxin oxidase</li><li>\u2022 not</li><li>\u2022 recognized</li><li>\u2022 selenocysteine</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Selenocysteine (SeCys) is seen at the active site of the following enzymes:</li><li>\u27a4 Selenocysteine (SeCys)</li><li>\u27a4 active site</li><li>\u27a4 Thioredoxin reductase Glutathione peroxidase , which scavenges peroxides Deiodinase that removes iodine from thyroxine to make triiodothyronine Selenoprotein P , a glycoprotein seen in mammalian blood</li><li>\u27a4 Thioredoxin reductase</li><li>\u27a4 Thioredoxin reductase</li><li>\u27a4 Glutathione peroxidase , which scavenges peroxides</li><li>\u27a4 Glutathione peroxidase</li><li>\u27a4 Deiodinase that removes iodine from thyroxine to make triiodothyronine</li><li>\u27a4 Deiodinase</li><li>\u27a4 Selenoprotein P , a glycoprotein seen in mammalian blood</li><li>\u27a4 Selenoprotein P</li><li>\u27a4 Ref : Vasudevan 9/e p 215.</li><li>\u27a4 Ref : Vasudevan 9/e p 215.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "23245888",
      "audio": ""
    },
    {
      "text": "Which of the following can be homologous substitution for isoleucine in a protein?",
      "options": [
        {
          "label": "A",
          "text": "Methionine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Aspartic acid",
          "correct": false
        },
        {
          "label": "C",
          "text": "Valine",
          "correct": true
        },
        {
          "label": "D",
          "text": "Arginine",
          "correct": false
        }
      ],
      "correct_answer": "C. Valine",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/18/picture13.jpg"
      ],
      "explanation": "<p><strong>Ans. C)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: Methionine - Although methionine is also nonpolar and relatively hydrophobic, it has a different side chain that includes a sulfur atom , which can affect the protein differently than valine or isoleucine.</li><li>\u2022 Option A: Methionine</li><li>\u2022 nonpolar</li><li>\u2022 relatively hydrophobic,</li><li>\u2022 different side chain</li><li>\u2022 sulfur atom</li><li>\u2022 can</li><li>\u2022 protein</li><li>\u2022 differently</li><li>\u2022 valine or isoleucine.</li><li>\u2022 Option B: Aspartic acid - This amino acid is polar and carries a negative charge at physiological pH , making it a non-homologous substitution for the nonpolar isoleucine.</li><li>\u2022 Option B: Aspartic acid</li><li>\u2022 amino acid</li><li>\u2022 polar</li><li>\u2022 carries a negative charge</li><li>\u2022 pH</li><li>\u2022 non-homologous</li><li>\u2022 substitution</li><li>\u2022 nonpolar isoleucine.</li><li>\u2022 Option D: Arginine - Arginine is a positively charged amino acid at physiological pH and is much larger, making it a non-homologous substitution for isoleucine.</li><li>\u2022 Option D: Arginine</li><li>\u2022 positively charged amino</li><li>\u2022 acid</li><li>\u2022 physiological pH</li><li>\u2022 larger,</li><li>\u2022 non-homologous</li><li>\u2022 substitution for isoleucine.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Conservative (Homologous) Substitution:</li><li>\u27a4 Conservative (Homologous) Substitution:</li><li>\u27a4 One amino acid replaced by another amino acid of similar characteristics Examples of homologous substitutio n is shown in the diagram given below.B</li><li>\u27a4 One amino acid replaced by another amino acid of similar characteristics</li><li>\u27a4 One amino acid</li><li>\u27a4 another amino acid</li><li>\u27a4 similar characteristics</li><li>\u27a4 Examples of homologous substitutio n is shown in the diagram given below.B</li><li>\u27a4 homologous substitutio</li><li>\u27a4 given below.B</li><li>\u27a4 Nonconservative (Nonhomologous) Substitution:</li><li>\u27a4 Nonconservative (Nonhomologous) Substitution:</li><li>\u27a4 One amino acid replaced by another amino acid of different characteristics</li><li>\u27a4 One amino acid replaced by another amino acid of different characteristics</li><li>\u27a4 One amino acid</li><li>\u27a4 another amino acid</li><li>\u27a4 different characteristics</li><li>\u27a4 Ref : Harper 30/e: p 390.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e: p 390.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9e04064e",
      "audio": ""
    },
    {
      "text": "A researcher is utilizing different analytical techniques to study protein structures. Each method has a specific utility in the determination of primary, secondary, tertiary, or quaternary structures of proteins. Among the listed techniques, which one does NOT directly determine the structure of proteins?",
      "options": [
        {
          "label": "A",
          "text": "High performance liquid chromatography",
          "correct": true
        },
        {
          "label": "B",
          "text": "Mass spectrometry",
          "correct": false
        },
        {
          "label": "C",
          "text": "X-ray crystallography",
          "correct": false
        },
        {
          "label": "D",
          "text": "NMR spectrometry",
          "correct": false
        }
      ],
      "correct_answer": "A. High performance liquid chromatography",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B: Mass spectrometry can determine the primary structure (sequence of amino acids) of proteins and post-translational modifications.</li><li>\u2022 Option B:</li><li>\u2022 Mass spectrometry</li><li>\u2022 primary structure</li><li>\u2022 amino acids)</li><li>\u2022 proteins</li><li>\u2022 post-translational</li><li>\u2022 modifications.</li><li>\u2022 Option C: X-ray crystallography is used to determine the three-dimensional structure of a protein at atomic resolution.</li><li>\u2022 Option C:</li><li>\u2022 X-ray crystallography</li><li>\u2022 used to</li><li>\u2022 three-dimensional structure of a protein</li><li>\u2022 atomic resolution.</li><li>\u2022 Option D: NMR spectrometry can provide detailed information about the structure and dynamics of proteins , particularly in solution.</li><li>\u2022 Option D:</li><li>\u2022 NMR spectrometry</li><li>\u2022 information</li><li>\u2022 structure and dynamics of proteins</li><li>\u2022 solution.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Methods for Separating and Purifying Biomolecules</li><li>\u27a4 Methods for Separating and Purifying Biomolecules</li><li>\u27a4 Salt fractionation (e.g., precipitation of proteins with ammonium sulfate ) Chromatography: Paper, ion exchange, affinity, thin-layer, gas-liquid, high-pressure liquid, gel filtration Electrophoresis : Paper, high-voltage, agarose, cellulose acetate, starch gel, polyacrylamide gel, SDS-polyacrylamide gel Ultracentrifugation</li><li>\u27a4 Salt fractionation (e.g., precipitation of proteins with ammonium sulfate )</li><li>\u27a4 Salt fractionation</li><li>\u27a4 precipitation of proteins</li><li>\u27a4 ammonium sulfate</li><li>\u27a4 Chromatography: Paper, ion exchange, affinity, thin-layer, gas-liquid, high-pressure liquid, gel filtration</li><li>\u27a4 Chromatography: Paper, ion exchange, affinity, thin-layer, gas-liquid, high-pressure liquid, gel filtration</li><li>\u27a4 Electrophoresis : Paper, high-voltage, agarose, cellulose acetate, starch gel, polyacrylamide gel, SDS-polyacrylamide gel</li><li>\u27a4 Electrophoresis</li><li>\u27a4 Paper, high-voltage, agarose, cellulose acetate, starch gel, polyacrylamide gel, SDS-polyacrylamide gel</li><li>\u27a4 Ultracentrifugation</li><li>\u27a4 Ultracentrifugation</li><li>\u27a4 Methods for Determining Biomolecular Structures</li><li>\u27a4 Methods for Determining Biomolecular Structures</li><li>\u27a4 Elemental analysis UV, visible, infrared, and NMR spectroscopy Use of acid or alkaline hydrolysis to degrade the biomolecule understudy into its basic constituents Use of a battery of enzymes of known specificity to degrade the biomolecule under study (e.g., proteases, nucleases, glycosidases ) Mass spectrometry Specific sequencing methods (e.g., for proteins and nucleic acids ) X-ray crystallography</li><li>\u27a4 Elemental analysis</li><li>\u27a4 Elemental analysis</li><li>\u27a4 UV, visible, infrared, and NMR spectroscopy</li><li>\u27a4 UV, visible, infrared, and NMR spectroscopy</li><li>\u27a4 Use of acid or alkaline hydrolysis to degrade the biomolecule understudy into its basic constituents</li><li>\u27a4 acid or alkaline</li><li>\u27a4 hydrolysis</li><li>\u27a4 degrade</li><li>\u27a4 basic constituents</li><li>\u27a4 Use of a battery of enzymes of known specificity to degrade the biomolecule under study (e.g., proteases, nucleases, glycosidases )</li><li>\u27a4 Use of a battery</li><li>\u27a4 enzymes</li><li>\u27a4 specificity</li><li>\u27a4 degrade the biomolecule</li><li>\u27a4 proteases, nucleases,</li><li>\u27a4 glycosidases</li><li>\u27a4 Mass spectrometry</li><li>\u27a4 Mass spectrometry</li><li>\u27a4 Specific sequencing methods (e.g., for proteins and nucleic acids )</li><li>\u27a4 Specific sequencing methods</li><li>\u27a4 proteins and nucleic acids</li><li>\u27a4 X-ray crystallography</li><li>\u27a4 X-ray crystallography</li><li>\u27a4 Ref : Harper 29/e: p 2, Vasudevan 9/e: p 45.</li><li>\u27a4 Ref : Harper 29/e: p 2, Vasudevan 9/e: p 45.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "abae8b44",
      "audio": ""
    },
    {
      "text": "Which organelle is primarily responsible for sorting proteins?",
      "options": [
        {
          "label": "A",
          "text": "Golgi Bodies",
          "correct": true
        },
        {
          "label": "B",
          "text": "Mitochondria",
          "correct": false
        },
        {
          "label": "C",
          "text": "Ribosomes",
          "correct": false
        },
        {
          "label": "D",
          "text": "Lysosomes",
          "correct": false
        }
      ],
      "correct_answer": "A. Golgi Bodies",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B: Mitochondria: Electron transport chain, ATP generation, TCA cycle, beta oxidation of fatty acids, ketone body production, urea synthesis (part), heme synthesis (part), gluconeogenesis (part), pyrimidine synthesis (part).</li><li>\u2022 Option B:</li><li>\u2022 Mitochondria:</li><li>\u2022 Option C: Ribosomes: Biosynthesis of proteins.</li><li>\u2022 Option C:</li><li>\u2022 Ribosomes:</li><li>\u2022 Option D: Lysosomes: Degradation of proteins, carbohydrates, lipids and nucleotides</li><li>\u2022 Option D:</li><li>\u2022 Lysosomes:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Functions of Golgi bodies:</li><li>\u27a4 Functions of Golgi bodies:</li><li>\u27a4 O-Glycosylation of proteins Protein sorting Processing of oligosaccharide chains of Glycoproteins</li><li>\u27a4 O-Glycosylation of proteins</li><li>\u27a4 Protein sorting</li><li>\u27a4 Processing of oligosaccharide chains of Glycoproteins</li><li>\u27a4 Ref : Harper 30/e: p 608.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e: p 608.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ad67e1e4",
      "audio": ""
    },
    {
      "text": "A graduate student is preparing a presentation on protein folding and the role of molecular chaperones in maintaining cellular protein homeostasis. While researching, the student encounters various facts about chaperones but realizes one of the statements they've noted is incorrect. Which of the following statements about chaperones is FALSE?",
      "options": [
        {
          "label": "A",
          "text": "Belong to heat shock Proteins",
          "correct": false
        },
        {
          "label": "B",
          "text": "Present from bacteria to human",
          "correct": false
        },
        {
          "label": "C",
          "text": "Ubiquitin is the most important chaperones",
          "correct": true
        },
        {
          "label": "D",
          "text": "Also known as Stress Proteins",
          "correct": false
        }
      ],
      "correct_answer": "C. Ubiquitin is the most important chaperones",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C)</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Some Properties of Chaperone Proteins:</li><li>\u27a4 Some Properties of Chaperone Proteins:</li><li>\u27a4 Present in a wide range of species from bacteria to humans Many are heat shock proteins (Hsp) and are known as stress proteins. Some are inducible by conditions which cause unfolding of newly synthesized proteins (e.g. elevated temperature and various chemicals). They bind to predominantly hydrophobic regions of unfolded proteins thus preventing their aggregation. They act as a quality control or editing mechanism for detecting misfolded or defective proteins. Most chaperones have associated ATPase activity, with ATP or ADP being involved in the protein-chaperone interaction. Found in various cellular compartments such as cytosol, mitochondria, and the lumen of the endoplasmic reticulum.</li><li>\u27a4 Present in a wide range of species from bacteria to humans</li><li>\u27a4 wide range of species from bacteria to humans</li><li>\u27a4 Many are heat shock proteins (Hsp) and are known as stress proteins.</li><li>\u27a4 heat shock proteins (Hsp)</li><li>\u27a4 stress proteins.</li><li>\u27a4 Some are inducible by conditions which cause unfolding of newly synthesized proteins (e.g. elevated temperature and various chemicals).</li><li>\u27a4 inducible</li><li>\u27a4 unfolding of newly synthesized proteins</li><li>\u27a4 elevated temperature</li><li>\u27a4 They bind to predominantly hydrophobic regions of unfolded proteins thus preventing their aggregation.</li><li>\u27a4 bind</li><li>\u27a4 hydrophobic</li><li>\u27a4 unfolded proteins</li><li>\u27a4 preventing their aggregation.</li><li>\u27a4 They act as a quality control or editing mechanism for detecting misfolded or defective proteins.</li><li>\u27a4 act</li><li>\u27a4 quality control</li><li>\u27a4 editing</li><li>\u27a4 detecting misfolded or defective proteins.</li><li>\u27a4 Most chaperones have associated ATPase activity, with ATP or ADP being involved in the protein-chaperone interaction.</li><li>\u27a4 Most chaperones</li><li>\u27a4 ATPase activity, with ATP or ADP</li><li>\u27a4 protein-chaperone interaction.</li><li>\u27a4 Found in various cellular compartments such as cytosol, mitochondria, and the lumen of the endoplasmic reticulum.</li><li>\u27a4 cellular compartments</li><li>\u27a4 cytosol, mitochondria, and the lumen of the endoplasmic reticulum.</li><li>\u27a4 Ref : Harper 30/e: p 609.</li><li>\u27a4 Ref : Harper 30/e: p 609.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d6fd6cc8",
      "audio": ""
    },
    {
      "text": "Is the statement \"Calreticulin is considered a chaperone protein\" correct?",
      "options": [
        {
          "label": "A",
          "text": "True",
          "correct": true
        },
        {
          "label": "B",
          "text": "False",
          "correct": false
        },
        {
          "label": "C",
          "text": "Insufficient Information",
          "correct": false
        },
        {
          "label": "D",
          "text": "None of the above",
          "correct": false
        }
      ],
      "correct_answer": "A. True",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A)</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Molecular Chaperones are</li><li>\u27a4 Molecular Chaperones are</li><li>\u27a4 HSP 70 HSP 90 HSP 40 [ Cochaperone ] BiP [ Immunoglobulin heavy chain binding protein ] Glucose Regulated Protein [GRP-94] Calreticulin Calnexin.</li><li>\u27a4 HSP 70</li><li>\u27a4 HSP 90</li><li>\u27a4 HSP 40 [ Cochaperone ]</li><li>\u27a4 Cochaperone</li><li>\u27a4 BiP [ Immunoglobulin heavy chain binding protein ]</li><li>\u27a4 BiP</li><li>\u27a4 Immunoglobulin</li><li>\u27a4 binding protein</li><li>\u27a4 Glucose Regulated Protein [GRP-94]</li><li>\u27a4 Glucose Regulated Protein</li><li>\u27a4 Calreticulin</li><li>\u27a4 Calreticulin</li><li>\u27a4 Calnexin.</li><li>\u27a4 Calnexin.</li><li>\u27a4 Ref : Harper 30/e: p 608-610.</li><li>\u27a4 Ref : Harper 30/e: p 608-610.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d7706dbf",
      "audio": ""
    },
    {
      "text": "Which group among the following is responsible for buffering activity of proteins at physiological pH?",
      "options": [
        {
          "label": "A",
          "text": "Sulfhydryl group",
          "correct": false
        },
        {
          "label": "B",
          "text": "Indole group",
          "correct": false
        },
        {
          "label": "C",
          "text": "Phenyl group",
          "correct": false
        },
        {
          "label": "D",
          "text": "Imidazole group",
          "correct": true
        }
      ],
      "correct_answer": "D. Imidazole group",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/18/picture28.jpg"
      ],
      "explanation": "<p><strong>Ans. D)</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Only amino acid whose pKa value (6.1) is nearby physiological pH (7.4) is Histidine ( Imidazole group ), due to which it has buffering activity at physiological pH.</li><li>\u27a4 amino acid</li><li>\u27a4 pKa value (6.1)</li><li>\u27a4 physiological pH (7.4)</li><li>\u27a4 Histidine</li><li>\u27a4 Imidazole group</li><li>\u27a4 buffering</li><li>\u27a4 activity</li><li>\u27a4 physiological pH.</li><li>\u27a4 Ref : Vasudevan 9/e: p 28.</li><li>\u27a4 Ref</li><li>\u27a4 : Vasudevan 9/e: p 28.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e2a9c5b2",
      "audio": ""
    },
    {
      "text": "During a biochemistry tutorial, the discussion focuses on the various levels of protein structure and the types of bonds that stabilize each level. A key topic is the primary structure of proteins and the specific type of bond that links amino acids together in a polypeptide chain. Which type of bond is involved in the formation of the primary structure of a protein or polypeptide?",
      "options": [
        {
          "label": "A",
          "text": "Covalent",
          "correct": false
        },
        {
          "label": "B",
          "text": "Peptide",
          "correct": false
        },
        {
          "label": "C",
          "text": "Amide Bond",
          "correct": false
        },
        {
          "label": "D",
          "text": "All of the above",
          "correct": true
        }
      ],
      "correct_answer": "D. All of the above",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/19/picture2.jpg"
      ],
      "explanation": "<p><strong>Ans. D)</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "51cb45bf",
      "audio": ""
    },
    {
      "text": "Following is an image of a Zinc finger domain of a steroid receptor. Which of the following molecule is stabilising Zinc in this structure?",
      "options": [
        {
          "label": "A",
          "text": "Finger-like projection",
          "correct": false
        },
        {
          "label": "B",
          "text": "Cysteine residues",
          "correct": true
        },
        {
          "label": "C",
          "text": "Leucine residues",
          "correct": false
        },
        {
          "label": "D",
          "text": "SH group of proteins",
          "correct": false
        }
      ],
      "correct_answer": "B. Cysteine residues",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/19/picture4.jpg"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/19/picture5.jpg"
      ],
      "explanation": "<p><strong>Ans. B)</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Other DNA binding domains with their functions are shown in the following table.</li><li>\u27a4 DNA binding domains</li><li>\u27a4 their functions</li><li>\u27a4 Ref : Harper 30/e: p 444</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e: p 444</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "bd3e9f19",
      "audio": ""
    },
    {
      "text": "In a discussion on protein synthesis, a molecular biology instructor outlines the role of aminoacyl tRNAs in the translation process. These molecules are essential for delivering the appropriate amino acids to the ribosome for incorporation into the growing polypeptide chain. However, one of the amino acids mentioned is not directly incorporated by this process. Which amino acid does not require an aminoacyl tRNA for its incorporation into a protein?",
      "options": [
        {
          "label": "A",
          "text": "Hydroxyproline",
          "correct": true
        },
        {
          "label": "B",
          "text": "Methionine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Cysteine",
          "correct": false
        },
        {
          "label": "D",
          "text": "Lysine",
          "correct": false
        }
      ],
      "correct_answer": "A. Hydroxyproline",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/19/picture7.jpg"
      ],
      "explanation": "<p><strong>Ans. A)</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Ref : Vasudevan 9/e: p 25.</li><li>\u27a4 Ref</li><li>\u27a4 : Vasudevan 9/e: p 25.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3bac7418",
      "audio": ""
    },
    {
      "text": "Assertion (A) : AIP (acute intermittent porphyria) has abdominal pain and neuropsychiatric features as common presentation. Reasoning (R) : The above symptoms are due to accumulation of ALA and PBG. ALA inhibits ATPase in the nervous system leads to conduction paralysis. Which of the following is the most appropriate interpretation of the Assertion and Reasoning provided?",
      "options": [
        {
          "label": "A",
          "text": "A and R both are right but R is not the correct explanation of A",
          "correct": false
        },
        {
          "label": "B",
          "text": "A and R both are wrong",
          "correct": false
        },
        {
          "label": "C",
          "text": "A is wrong but R is a right statement",
          "correct": false
        },
        {
          "label": "D",
          "text": "A as well as R are right and R is a correct explanation of A",
          "correct": true
        }
      ],
      "correct_answer": "D. A as well as R are right and R is a correct explanation of A",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/19/picture8.jpg"
      ],
      "explanation": "<p><strong>Ans. D)</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Acute Intermittent Porphyria (AIP) is marked by a lack of porphobilinogen deaminase , causing delta-aminolevulinic acid and porphobilinogen buildup , leading to abdominal pain and neuropsychiatric symptoms . This is due to ALA's neurotoxicity, which inhibits ATPase in neurons, resulting in neuronal dysfunction and paralysis.</li><li>\u27a4 Acute Intermittent Porphyria (AIP)</li><li>\u27a4 lack of porphobilinogen deaminase</li><li>\u27a4 delta-aminolevulinic acid</li><li>\u27a4 porphobilinogen buildup</li><li>\u27a4 abdominal pain and neuropsychiatric symptoms</li><li>\u27a4 due to ALA's neurotoxicity,</li><li>\u27a4 inhibits ATPase in neurons,</li><li>\u27a4 neuronal dysfunction and paralysis.</li><li>\u27a4 Ref : Harper 30/e:  p 328-329</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e:  p 328-329</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "572af5e0",
      "audio": ""
    },
    {
      "text": "A 12-year-old boy presents to the pediatric clinic with a notably disfigured face, pronounced photosensitivity, stained teeth, and laboratory tests revealing elevated levels of Coproporphyrin-I. Based on these clinical findings, which enzyme deficiency is most likely responsible for this patient's condition?",
      "options": [
        {
          "label": "A",
          "text": "Uroporphyrinogen Synthase",
          "correct": false
        },
        {
          "label": "B",
          "text": "Uroporphyrinogen III Synthase",
          "correct": true
        },
        {
          "label": "C",
          "text": "Uroporphyrinogen Decarboxylase",
          "correct": false
        },
        {
          "label": "D",
          "text": "Coproporphyrinogen Oxidase",
          "correct": false
        }
      ],
      "correct_answer": "B. Uroporphyrinogen III Synthase",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B)</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Congenital Erythropoietic Porphyria (CEP), a rare disorder caused by a deficiency in Uroporphyrinogen III Synthase. The accumulation of specific porphyrins leads to symptoms including photosensitivity, facial disfigurement, and stained teeth, emphasizing the critical role of the heme biosynthesis pathway in maintaining normal physiological functions and the diverse clinical manifestations that can arise from its disruption.</li><li>\u27a4 Congenital Erythropoietic Porphyria (CEP),</li><li>\u27a4 rare disorder</li><li>\u27a4 deficiency in Uroporphyrinogen III Synthase.</li><li>\u27a4 specific porphyrins</li><li>\u27a4 photosensitivity, facial disfigurement, and stained teeth,</li><li>\u27a4 emphasizing</li><li>\u27a4 heme biosynthesis pathway</li><li>\u27a4 normal physiological functions</li><li>\u27a4 diverse</li><li>\u27a4 clinical manifestations</li><li>\u27a4 arise</li><li>\u27a4 its disruption.</li><li>\u27a4 Ref : Harper 30/e: p 327-329</li><li>\u27a4 Ref : Harper 30/e: p 327-329</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6f983ca3",
      "audio": ""
    },
    {
      "text": "A 3.5-year-old girl of Arabian descent presents to the clinic with severe anemia, thrombocytopenia, leukocytosis, and elevated ESR. The history provided by her parents includes fever, cough, pallor, weakness, and tachypnea. On examination, hepatomegaly is noted. Following diagnostic evaluations, sickle cell anemia (SCA) is diagnosed. Based on the information provided, which of the following statements about SCA is false?",
      "options": [
        {
          "label": "A",
          "text": "RFLP result from a single base change",
          "correct": false
        },
        {
          "label": "B",
          "text": "Single nucleotide change results in change of Glutamate to Valine",
          "correct": false
        },
        {
          "label": "C",
          "text": "HbS confers resistance against malaria in heterozygotes",
          "correct": false
        },
        {
          "label": "D",
          "text": "\u2018Sticky patch\u2019 is generated as a result of replacement of a nonpolar residue with a polar residue in Sickle Cell Anemia (HbS)",
          "correct": true
        }
      ],
      "correct_answer": "D. \u2018Sticky patch\u2019 is generated as a result of replacement of a nonpolar residue with a polar residue in Sickle Cell Anemia (HbS)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) \u2018Sticky patch\u2019 is generated as a result of replacement of a nonpolar residue with a polar residue in Sickle Cell Anemia (HbS) \u2014 this is False.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 In sickle cell anemia , the amino acid substitution involves replacing a polar residue Glutamate with a nonpolar residue (valine) at the 6th position of the \u03b2-globin chain.</li><li>\u2022 sickle cell anemia</li><li>\u2022 polar residue Glutamate</li><li>\u2022 nonpolar residue (valine)</li><li>\u2022 This substitution creates a hydrophobic \u201csticky patch\u201d on the surface of the deoxygenated hemoglobin S (HbS) molecule. These hydrophobic patches interact abnormally with each other, leading to polymerization of HbS inside red cells, which causes the characteristic \"sickling\" shape of RBCs under hypoxic conditions.</li><li>\u2022 hydrophobic \u201csticky patch\u201d</li><li>\u2022 polymerization of HbS</li><li>\u2022 So the false statement is that the \u201csticky patch\u201d arises from a nonpolar \u2192 polar substitution \u2014 the reality is the opposite: \u2192 It\u2019s a polar (glutamate) \u2192 nonpolar (valine) substitution.</li><li>\u2022 nonpolar \u2192 polar substitution</li><li>\u2022 polar (glutamate) \u2192 nonpolar (valine)</li><li>\u2022 Other Options:</li><li>\u2022 Other Options:</li><li>\u2022 Option A) RFLP result from a single base change: Correct \u2014 The sickle cell mutation involves a single nucleotide change ( A \u2192 T at the 6th codon), which eliminates a restriction enzyme site. This difference can be detected using Restriction Fragment Length Polymorphism (RFLP) analysis. Option B) Single nucleotide change results in change of Glutamate to Valine: Correction: this statement is Correct . Option C) HbS confers resistance against malaria in heterozygotes: Correct \u2014 Heterozygotes for the HbS gene (sickle cell trait) are relatively protected against Plasmodium falciparum malaria , explaining its evolutionary persistence in malaria-endemic regions.</li><li>\u2022 Option A) RFLP result from a single base change: Correct \u2014 The sickle cell mutation involves a single nucleotide change ( A \u2192 T at the 6th codon), which eliminates a restriction enzyme site. This difference can be detected using Restriction Fragment Length Polymorphism (RFLP) analysis.</li><li>\u2022 Option A) RFLP result from a single base change:</li><li>\u2022 A \u2192 T</li><li>\u2022 Restriction Fragment Length Polymorphism (RFLP)</li><li>\u2022 Option B) Single nucleotide change results in change of Glutamate to Valine: Correction: this statement is Correct .</li><li>\u2022 Option B) Single nucleotide change results in change of Glutamate to Valine:</li><li>\u2022 Correction:</li><li>\u2022 Correct</li><li>\u2022 Option C) HbS confers resistance against malaria in heterozygotes: Correct \u2014 Heterozygotes for the HbS gene (sickle cell trait) are relatively protected against Plasmodium falciparum malaria , explaining its evolutionary persistence in malaria-endemic regions.</li><li>\u2022 Option C) HbS confers resistance against malaria in heterozygotes:</li><li>\u2022 Plasmodium falciparum malaria</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In Sickle Cell Anemia (SCA) , a single point mutation (A \u2192 T) at the 6th codon of the \u03b2-globin gene results in the substitution of Glutamate (polar) with valine (nonpolar) . This creates a hydrophobic site (\"sticky patch\") on deoxygenated HbS, triggering polymerization, red cell sickling, hemolysis, and vaso-occlusive complications.</li><li>\u27a4 Sickle Cell Anemia (SCA)</li><li>\u27a4 \u03b2-globin gene</li><li>\u27a4 Glutamate (polar)</li><li>\u27a4 valine (nonpolar)</li><li>\u27a4 Ref: Harper 30/e p 417, 693.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f65d65ee",
      "audio": ""
    },
    {
      "text": "A 40-year-old male presents to the clinic with a history of skin fragility and blistering on sun-exposed areas. He also reports significant liver disease history and excessive alcohol consumption. Laboratory tests show elevated porphyrins in urine. The patient's symptoms and laboratory findings suggest a diagnosis related to porphyrin metabolism. Which of the following types of porphyria is characterized by a deficiency in the enzyme uroporphyrinogen decarboxylase?",
      "options": [
        {
          "label": "A",
          "text": "Acute intermittent porphyria",
          "correct": false
        },
        {
          "label": "B",
          "text": "Porphyria cutanea tarda",
          "correct": true
        },
        {
          "label": "C",
          "text": "Congenital erythropoietic porphyria",
          "correct": false
        },
        {
          "label": "D",
          "text": "Hereditary coproporphyria",
          "correct": false
        }
      ],
      "correct_answer": "B. Porphyria cutanea tarda",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: A cute intermittent porphyria: Deficiency of Uroporphyrinogen I synthase ; C/F- Abdominal pain, neuropsychiatric symptoms with increased urinary ALA and PBG.</li><li>\u2022 Option A: A</li><li>\u2022 cute intermittent porphyria:</li><li>\u2022 Uroporphyrinogen I synthase</li><li>\u2022 Abdominal pain, neuropsychiatric</li><li>\u2022 symptoms</li><li>\u2022 increased urinary ALA and PBG.</li><li>\u2022 Option C: C ongenital erythropoietic porphyria: Deficiency of Uroporphyrinogen III synthase ; C/F- Photosensitivity with increased u roporphyrin I in urinary, faecal, and red cells.</li><li>\u2022 Option C: C</li><li>\u2022 ongenital erythropoietic porphyria:</li><li>\u2022 Uroporphyrinogen III synthase</li><li>\u2022 Photosensitivity with increased</li><li>\u2022 roporphyrin I</li><li>\u2022 urinary, faecal, and red cells.</li><li>\u2022 Option D: Hereditary coproporphyria: Deficiency of Coproporphyrinogen oxidase ; C/F -Photosensitivity, abdominal pain, neuropsychiatric symptoms with urinary ALA, PBG , and coproporphyrin III and faecal coproporphyrin III increased.</li><li>\u2022 Option D:</li><li>\u2022 Hereditary coproporphyria:</li><li>\u2022 Coproporphyrinogen oxidase</li><li>\u2022 -Photosensitivity, abdominal pain,</li><li>\u2022 neuropsychiatric symptoms</li><li>\u2022 urinary ALA, PBG</li><li>\u2022 coproporphyrin III</li><li>\u2022 faecal coproporphyrin III increased.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Porphyria cutanea tarda (PCT) is the most common form of porphyria and is characterized by a deficiency of the enzyme uroporphyrinogen decarboxylase (UROD).</li><li>\u27a4 Porphyria cutanea tarda (PCT)</li><li>\u27a4 porphyria</li><li>\u27a4 deficiency of the enzyme</li><li>\u27a4 uroporphyrinogen decarboxylase (UROD).</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 274.</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 274.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "2a137c28",
      "audio": ""
    },
    {
      "text": "A 3-year-old male child presents to the pediatric outpatient department with a history of recurrent gastrointestinal disturbances and lethargy over the past few weeks. Laboratory investigations reveal a microcytic, hypochromic anemia and elevated blood lead levels, suggestive of lead poisoning. Given this child's condition, which of the following enzymes would likely exhibit increased activity in the liver as a compensatory or pathophysiological response?",
      "options": [
        {
          "label": "A",
          "text": "Bilirubin UDP-glucuronosyltransferase",
          "correct": false
        },
        {
          "label": "B",
          "text": "Ferrochelatase",
          "correct": false
        },
        {
          "label": "C",
          "text": "Heme oxygenase",
          "correct": false
        },
        {
          "label": "D",
          "text": "\u03b4-Aminolevulinic acid synthase",
          "correct": true
        }
      ],
      "correct_answer": "D. \u03b4-Aminolevulinic acid synthase",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) \u03b4 -Aminolevulinic acid synthase</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: Bilirubin UDP-glucuronosyltransferase: This enzyme is involved in the conjugation of bilirubin , not directly affected in lead poisoning.</li><li>\u2022 Option A: Bilirubin UDP-glucuronosyltransferase:</li><li>\u2022 conjugation of bilirubin</li><li>\u2022 Option B: Ferrochelatase: Lead poisoning actually inhibits ferrochelatase, decreasing its activity . Ferrochelatase catalyzes the insertion of iron into protoporphyrin IX to form heme .</li><li>\u2022 Option B: Ferrochelatase:</li><li>\u2022 Lead poisoning</li><li>\u2022 inhibits ferrochelatase, decreasing its activity</li><li>\u2022 Ferrochelatase</li><li>\u2022 insertion of iron</li><li>\u2022 protoporphyrin IX</li><li>\u2022 heme</li><li>\u2022 Option C: Heme oxygenase: This enzyme catalyzes the degradation of heme to biliverdin, free iron, and carbon monoxide . It is not specifically upregulated in lead poisoning.</li><li>\u2022 Option C: Heme oxygenase:</li><li>\u2022 degradation of heme to biliverdin, free iron, and carbon monoxide</li><li>\u2022 not</li><li>\u2022 upregulated</li><li>\u2022 lead poisoning.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The effects of lead poisoning on the heme biosynthesis pathway, particularly the inhibition of specific enzymes like ALA dehydratase and ferrochelatase, leading to a compensatory increase in \u03b4-ALAS activity.</li><li>\u27a4 effects of lead poisoning</li><li>\u27a4 heme biosynthesis pathway,</li><li>\u27a4 inhibition of specific enzymes like ALA dehydratase</li><li>\u27a4 ferrochelatase,</li><li>\u27a4 compensatory increase</li><li>\u27a4 \u03b4-ALAS activity.</li><li>\u27a4 Ref : Harper 30/e: p 326-327, 334.</li><li>\u27a4 Ref : Harper 30/e: p 326-327, 334.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "bb6845d5",
      "audio": ""
    },
    {
      "text": "Which of the following statements is true regarding the interaction of hemoglobin with 2, 3-BPG",
      "options": [
        {
          "label": "A",
          "text": "2, 3 BPG is an intermediate of Gluconeogenesis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Binding of 2,3 BPG decreases the affinity of Hb to O2 and shifts the ODC to right",
          "correct": true
        },
        {
          "label": "C",
          "text": "Binding of 2,3 BPG stabilises the R state",
          "correct": false
        },
        {
          "label": "D",
          "text": "2, 3 BPG has increased interaction with HbF",
          "correct": false
        }
      ],
      "correct_answer": "B. Binding of 2,3 BPG decreases the affinity of Hb to O2 and shifts the ODC to right",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/19/picture18.jpg"
      ],
      "explanation": "<p><strong>Ans. B)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: 2, 3-BPG is an intermediate of gluconeogenesis: This statement is incorrect. 2, 3-BPG is formed from 1,3-bisphosphoglycerate during glycolysis, not gluconeogenesis.</li><li>\u2022 Option A: 2, 3-BPG is an intermediate of gluconeogenesis:</li><li>\u2022 incorrect.</li><li>\u2022 2, 3-BPG</li><li>\u2022 1,3-bisphosphoglycerate</li><li>\u2022 glycolysis, not gluconeogenesis.</li><li>\u2022 Option C: Binding of 2,3-BPG stabilizes the R state: This is incorrect. 2, 3-BPG binds to and stabilizes the T (tense) state of Hb , not the R (relaxed) state , which has a higher affinity for oxygen.</li><li>\u2022 Option C: Binding of 2,3-BPG stabilizes the R state:</li><li>\u2022 incorrect.</li><li>\u2022 2, 3-BPG</li><li>\u2022 T (tense) state of Hb</li><li>\u2022 not</li><li>\u2022 R (relaxed) state</li><li>\u2022 higher affinity for oxygen.</li><li>\u2022 Option D: 2, 3-BPG has increased interaction with HbF: This is incorrect . HbF has a lower affinity for 2, 3-BPG than adult hemoglobin (HbA), which contributes to its higher affinity for oxygen , facilitating oxygen transfer from the mother to the fetus.</li><li>\u2022 Option D:</li><li>\u2022 2, 3-BPG has increased interaction with HbF:</li><li>\u2022 incorrect</li><li>\u2022 HbF</li><li>\u2022 lower affinity for 2, 3-BPG</li><li>\u2022 adult hemoglobin</li><li>\u2022 its higher affinity for oxygen</li><li>\u2022 facilitating oxygen</li><li>\u2022 mother to the fetus.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 2, 3-BPG is a metabolite in the glycolytic pathway that binds to deoxyhemoglobin ( Hb in the T or tense state) and stabilizes it , which decreases the oxygen affinity of Hb . This interaction is crucial for the release of O2 in tissues.</li><li>\u27a4 2, 3-BPG</li><li>\u27a4 metabolite</li><li>\u27a4 glycolytic pathway</li><li>\u27a4 deoxyhemoglobin</li><li>\u27a4 Hb</li><li>\u27a4 T or tense state)</li><li>\u27a4 stabilizes it</li><li>\u27a4 decreases</li><li>\u27a4 oxygen affinity of Hb</li><li>\u27a4 interaction</li><li>\u27a4 release of O2 in tissues.</li><li>\u27a4 Binding of 2, 3-BPG to Hb thus facilitates the delivery of oxygen to tissues by promoting the release of oxygen from Hb , which is reflected as a rightward shift in the ODC.</li><li>\u27a4 2, 3-BPG to Hb</li><li>\u27a4 facilitates the delivery of oxygen</li><li>\u27a4 promoting the release of oxygen</li><li>\u27a4 Hb</li><li>\u27a4 rightward shift in the ODC.</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 288.</li><li>\u27a4 Ref</li><li>\u27a4 : DM Vasudevan 9/e: p 288.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "77cee663",
      "audio": ""
    },
    {
      "text": "Based on the picture shown to you, which of the following statements is correct?",
      "options": [
        {
          "label": "A",
          "text": "It is a basic structure of sphingophospholipids",
          "correct": false
        },
        {
          "label": "B",
          "text": "Sphingosine + fatty acid forms sphingomyelin",
          "correct": false
        },
        {
          "label": "C",
          "text": "It is a basic structure of Glycosphingolipids",
          "correct": true
        },
        {
          "label": "D",
          "text": "There are 2 types of glycolipids \u2013 cerebroside & ganglioside",
          "correct": false
        }
      ],
      "correct_answer": "C. It is a basic structure of Glycosphingolipids",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/10/picture1_Zrl1GM1.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A: Incorrect because sphingophospholipids have a phosphate group , which is not shown in the picture.</li><li>\u2022 Option A:</li><li>\u2022 Incorrect</li><li>\u2022 sphingophospholipids</li><li>\u2022 phosphate group</li><li>\u2022 not</li><li>\u2022 picture.</li><li>\u2022 Option B: Incorrect because sphingomyelin is a type of sphingophospholipid and would include a phosphocholine or phosphoethanolamine group, not shown in the diagram.</li><li>\u2022 Option B:</li><li>\u2022 Incorrect</li><li>\u2022 sphingomyelin</li><li>\u2022 type of sphingophospholipid</li><li>\u2022 phosphocholine</li><li>\u2022 phosphoethanolamine</li><li>\u2022 not</li><li>\u2022 diagram.</li><li>\u2022 Option D: Correct in the classification of glycolipids but not relevant to the structure shown in the image.</li><li>\u2022 Option D: Correct</li><li>\u2022 classification of glycolipids</li><li>\u2022 not</li><li>\u2022 shown in the image.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Glycosphingolipids (Glycolipids) do not contain phosphoric acid; instead contain carbohydrates and Ceramide ( sphingosine + fatty acid in amide linkage ) Contains 2 major subtypes : Glucocerebroside & Galactocerebroside Sphingomyelins are the only sphingolipid that contain phosphate and have no sugar moiety</li><li>\u27a4 Glycosphingolipids (Glycolipids) do not contain phosphoric acid; instead contain carbohydrates and Ceramide ( sphingosine + fatty acid in amide linkage )</li><li>\u27a4 Glycosphingolipids (Glycolipids)</li><li>\u27a4 do not</li><li>\u27a4 phosphoric acid;</li><li>\u27a4 carbohydrates and Ceramide</li><li>\u27a4 sphingosine + fatty acid</li><li>\u27a4 amide linkage</li><li>\u27a4 Contains 2 major subtypes : Glucocerebroside & Galactocerebroside</li><li>\u27a4 2 major subtypes</li><li>\u27a4 Glucocerebroside & Galactocerebroside</li><li>\u27a4 Sphingomyelins are the only sphingolipid that contain phosphate and have no sugar moiety</li><li>\u27a4 Sphingomyelins</li><li>\u27a4 sphingolipid</li><li>\u27a4 phosphate</li><li>\u27a4 no sugar moiety</li><li>\u27a4 Ref : Harper 30/e: p 250, Vasudevan 9/ed: p 108</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e: p 250, Vasudevan 9/ed: p 108</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a13dd687",
      "audio": ""
    },
    {
      "text": "In a neonatal intensive care unit at a research-focused hospital in India, a preterm newborn is admitted with signs of respiratory distress. The baby's mother had a complicated pregnancy, which led to early labor. The neonatologist considers the biochemical aspects that could be contributing to the baby's condition, specifically focusing on the surfactant composition in the baby\u2019s lungs. A deficiency in one of the surfactant components is suspected. Which lipid component could be deficient in this preterm newborn, contributing to respiratory distress?",
      "options": [
        {
          "label": "A",
          "text": "Cardiolipin",
          "correct": false
        },
        {
          "label": "B",
          "text": "Dipalmitoyl phosphatidyl choline",
          "correct": true
        },
        {
          "label": "C",
          "text": "Phosphatidyl ethanolamine",
          "correct": false
        },
        {
          "label": "D",
          "text": "Phosphatidyl inositol",
          "correct": false
        }
      ],
      "correct_answer": "B. Dipalmitoyl phosphatidyl choline",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: Cardiolipin: or Di phosphatidylglycerol is a major lipid of mitochondrial membrane and extracted from myocardium. Decreased cardiolipin level results in mitochondrial dysfunction, heart failure, hypothyroidism, and myopathies.</li><li>\u2022 Option A:</li><li>\u2022 Cardiolipin:</li><li>\u2022 Di phosphatidylglycerol</li><li>\u2022 mitochondrial membrane</li><li>\u2022 myocardium.</li><li>\u2022 Decreased cardiolipin level</li><li>\u2022 mitochondrial dysfunction, heart failure, hypothyroidism, and myopathies.</li><li>\u2022 Option C: Phosphatidyl ethanolamine: or Cephalin is found in bio membranes and possess amphipathic properties.</li><li>\u2022 Option C:</li><li>\u2022 Phosphatidyl ethanolamine:</li><li>\u2022 Cephalin</li><li>\u2022 bio membranes</li><li>\u2022 amphipathic</li><li>\u2022 Option D: Phosphatidyl inositol: or PIP2 is present in bio membranes and plays important role in mediation of hormone action on bio membranes and also acts as a second messenger.</li><li>\u2022 Option D:</li><li>\u2022 Phosphatidyl inositol:</li><li>\u2022 PIP2</li><li>\u2022 bio membranes</li><li>\u2022 mediation of hormone action</li><li>\u2022 bio membranes</li><li>\u2022 acts as a second messenger.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Dipalmitoyl phosphatidylcholine (DPPC) is the major component of lung surfactant , which reduces surface tension in the alveoli, preventing collapse during exhalation . In preterm babies, surfactant production can be insufficient , leading to respiratory distress syndrome (RDS).</li><li>\u27a4 Dipalmitoyl phosphatidylcholine (DPPC)</li><li>\u27a4 lung surfactant</li><li>\u27a4 reduces surface tension</li><li>\u27a4 alveoli,</li><li>\u27a4 preventing collapse during exhalation</li><li>\u27a4 preterm babies,</li><li>\u27a4 surfactant</li><li>\u27a4 insufficient</li><li>\u27a4 respiratory distress</li><li>\u27a4 syndrome (RDS).</li><li>\u27a4 Ref : Harper 30/e :  p 216 , Lippincott 7/e : P 204</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e :  p 216 , Lippincott 7/e : P 204</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e7ce3bfe",
      "audio": ""
    },
    {
      "text": "Assertion (A) : Niemann-Pick disease is a glycogen storage disease characterized by mental retardation, organomegaly, etc. Reasoning (R) : This is due to deficiency of enzyme hexosaminidase A. Choose the appropriate response.",
      "options": [
        {
          "label": "A",
          "text": "A and R both are right, but R is not the Correct explanation of A",
          "correct": false
        },
        {
          "label": "B",
          "text": "A and R both are wrong",
          "correct": true
        },
        {
          "label": "C",
          "text": "A is wrong but R is a right statement",
          "correct": false
        },
        {
          "label": "D",
          "text": "A as well as R are right, and R is a correct explanation of A",
          "correct": false
        }
      ],
      "correct_answer": "B. A and R both are wrong",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Niemann-Pick disease is a sphingolipidoses due to deficiency of the enzyme Sphingomyelinase Lipid accumulating - Sphingomyelin C/F: Enlarged liver and spleen, mental retardation and highly fatal in early life</li><li>\u2022 Niemann-Pick disease is a sphingolipidoses due to deficiency of the enzyme Sphingomyelinase</li><li>\u2022 Niemann-Pick disease</li><li>\u2022 sphingolipidoses</li><li>\u2022 deficiency</li><li>\u2022 Sphingomyelinase</li><li>\u2022 Lipid accumulating - Sphingomyelin</li><li>\u2022 Lipid accumulating</li><li>\u2022 Sphingomyelin</li><li>\u2022 C/F: Enlarged liver and spleen, mental retardation and highly fatal in early life</li><li>\u2022 Enlarged liver and spleen, mental retardation</li><li>\u2022 fatal in early life</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 Niemann-Pick disease is not a glycogen storage disease; a type of lysosomal storage disorder characterized by the accumulation of sphingomyelin due to the deficiency of the enzyme sphingomyelinase . This leads to symptoms such as mental retardation and organomegaly. Hexosaminidase A deficiency, on the other hand, causes Tay-Sachs disease, not Niemann-Pick disease.</li><li>\u2022 Niemann-Pick disease</li><li>\u2022 not</li><li>\u2022 glycogen storage disease;</li><li>\u2022 lysosomal storage disorder</li><li>\u2022 accumulation</li><li>\u2022 sphingomyelin</li><li>\u2022 deficiency of the enzyme sphingomyelinase</li><li>\u2022 mental retardation</li><li>\u2022 organomegaly. Hexosaminidase A deficiency,</li><li>\u2022 other hand,</li><li>\u2022 Tay-Sachs disease,</li><li>\u2022 not</li><li>\u2022 Ref : Harper 30/e page 251</li><li>\u2022 Ref</li><li>\u2022 : Harper 30/e page 251</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "61b8eba3",
      "audio": ""
    },
    {
      "text": "A medical researcher is exploring the immunological properties of different phospholipids. During a study designed to understand the role of phospholipids in autoimmune disorders, they isolate various phospholipids from cell membranes and assess their potential antigenic properties. Which of the following phospholipids possesses antigenic properties?",
      "options": [
        {
          "label": "A",
          "text": "Plasmalogens",
          "correct": false
        },
        {
          "label": "B",
          "text": "Cardiolipin",
          "correct": true
        },
        {
          "label": "C",
          "text": "Phosphatidylinositol",
          "correct": false
        },
        {
          "label": "D",
          "text": "Lecithin",
          "correct": false
        }
      ],
      "correct_answer": "B. Cardiolipin",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: Plasmalogens are found in bio membranes in brain and muscle.</li><li>\u2022 Option A:</li><li>\u2022 Plasmalogens</li><li>\u2022 bio membranes in brain and muscle.</li><li>\u2022 Option C: Phosphatidylinositol acts as a second messenger and plays a vital role in the mediation of hormone action on bio membranes.</li><li>\u2022 Option C:</li><li>\u2022 Phosphatidylinositol</li><li>\u2022 second messenger</li><li>\u2022 mediation of hormone</li><li>\u2022 Option D: Dipalmitoyl Lecithin / Di Palmitoyl Phosphatidyl Choline is the most abundant phospholipid of cell membrane, largest body store of choline and a major constituent of lung surfactant .</li><li>\u2022 Option D:</li><li>\u2022 Dipalmitoyl Lecithin / Di Palmitoyl Phosphatidyl Choline</li><li>\u2022 abundant phospholipid of cell membrane,</li><li>\u2022 body store of choline</li><li>\u2022 lung surfactant</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Cardiolipin is a phospholipid that has antigenic properties and can be involved in autoimmune responses , such as in the case of anti-phospholipid syndrome. It is commonly associated with syphilis, where it is the reactive agent in the Wassermann test, and with lupus, where it is targeted by anti-cardiolipin antibodies.</li><li>\u27a4 Cardiolipin</li><li>\u27a4 phospholipid</li><li>\u27a4 antigenic properties</li><li>\u27a4 autoimmune responses</li><li>\u27a4 anti-phospholipid syndrome.</li><li>\u27a4 syphilis,</li><li>\u27a4 reactive agent</li><li>\u27a4 Wassermann test,</li><li>\u27a4 lupus,</li><li>\u27a4 anti-cardiolipin antibodies.</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 108</li><li>\u27a4 Ref</li><li>\u27a4 : DM Vasudevan 9/e: p 108</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "19e2f2af",
      "audio": ""
    },
    {
      "text": "Which of the following diseases is least likely to include neurological symptoms in its classic presentation?",
      "options": [
        {
          "label": "A",
          "text": "Tay-Sachs disease",
          "correct": false
        },
        {
          "label": "B",
          "text": "Niemann-Pick disease",
          "correct": false
        },
        {
          "label": "C",
          "text": "Gaucher\u2019s disease",
          "correct": true
        },
        {
          "label": "D",
          "text": "GM 1 gangliosidoses",
          "correct": false
        }
      ],
      "correct_answer": "C. Gaucher\u2019s disease",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C)\u00a0Gaucher\u2019s disease</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Option A: Tay-Sachs disease : C/F: Neurological Symptoms, Mental retardation. Cherry red spot in the macula. Progressive deterioration No Hepatosplenomegaly.</li><li>\u2022 Option A: Tay-Sachs disease</li><li>\u2022 Option B: Niemann-Pick disease : C/F:  Severe CNS damage, mental retardation, hepatosplenomegaly, Cherry red spot in macula.</li><li>\u2022 Option B: Niemann-Pick disease</li><li>\u2022 Option D: GM1 gangliosidoses : C/F: Mental retardation, hepatomegaly, skeletal deformities. Angiokeratoma. Cherry red spot in the retina.</li><li>\u2022 Option D: GM1 gangliosidoses</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Gaucher's disease, particularly type 1, which is the most common form, does not usually present with neurological symptoms. This type is known as non-neuronopathic and primarily affects the spleen, liver, and bones.</li><li>\u27a4 Ref: DM Vasudevan 9/e: p 260, 261.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "abe774e4",
      "audio": ""
    },
    {
      "text": "A pediatrician evaluating a 6-month-old girl brought in by her mother. The baby has a history of repeated infections, fever, vomiting, and one seizure episode. There's a significant family history: an elder brother passed away at 3 years old from an undiagnosed condition. The baby appears lethargic and hypotonic, with bilateral nystagmus and a cherry red spot visible in both eyes. A blood examination reveals a decreased level of Hexosaminidase A enzyme, prompting the pediatrician to consider a genetic metabolic disorder. What is the most probable diagnosis for this baby?",
      "options": [
        {
          "label": "A",
          "text": "Gaucher\u2019s disease",
          "correct": false
        },
        {
          "label": "B",
          "text": "Niemann Pick disease",
          "correct": false
        },
        {
          "label": "C",
          "text": "Tay-Sachs disease",
          "correct": true
        },
        {
          "label": "D",
          "text": "Sandhoff's disease",
          "correct": false
        }
      ],
      "correct_answer": "C. Tay-Sachs disease",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/10/2_8cdDTT6.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Tay-Sachs disease</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Option A: Gaucher\u2019s disease type 1 : Due to deficiency of beta-glucocerebrosidase, C/F: Enlarged liver and spleen, erosion of long bones, no mental retardation, no cherry red spot</li><li>\u2022 Option A: Gaucher\u2019s disease type 1</li><li>\u2022 Option B: Niemann Pick disease : Due to deficiency of Sphingomyelinase. C/F: Mental retardation, blindness, muscular weakness, hepatosplenomegaly with Cherry red spot in macula. Death by 2 years of age.</li><li>\u2022 Option B: Niemann Pick disease</li><li>\u2022 Option D: Sandhoff\u2019s disease : Due to deficiency of Hexosaminidase A and B, c/f: Neurological deficit and MR with cherry red spot.</li><li>\u2022 Option D: Sandhoff\u2019s disease</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Tay-Sachs disease is a genetic disorder characterized by the absence or insufficient activity of an enzyme called Hexosaminidase A, leading to the accumulation of GM2 ganglioside within lysosomes, causing progressive neurological damage.</li><li>\u27a4 Ref: Harper 30/e: p 68,251.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3eb43172",
      "audio": ""
    },
    {
      "text": "A general practitioner examines a 5-year-old boy who has been brought in due to concerns about his slow development and physical health. The child has noticeable abdominal swelling and a history of unsteady gait leading to frequent falls. Recently, he experienced a convulsive episode that prompted this visit. Clinical examination reveals significant hepatosplenomegaly. Laboratory investigations, including a bone marrow biopsy, show lipid-laden foam histiocytes, and an enzyme assay indicates sphingomyelinase deficiency in the child's white blood cells?",
      "options": [
        {
          "label": "A",
          "text": "Gaucher\u2019s disease",
          "correct": false
        },
        {
          "label": "B",
          "text": "Niemann Pick disease",
          "correct": true
        },
        {
          "label": "C",
          "text": "Tay-Sachs disease",
          "correct": false
        },
        {
          "label": "D",
          "text": "Sandhoffs disease",
          "correct": false
        }
      ],
      "correct_answer": "B. Niemann Pick disease",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: Gaucher\u2019s disease type 1: Due to deficiency of beta-glucocerebrosidase, C/F: Enlarged liver and spleen, erosion of long bones, mental retardation in infants but no cherry red spot</li><li>\u2022 Option A: Gaucher\u2019s disease type 1:</li><li>\u2022 deficiency of beta-glucocerebrosidase,</li><li>\u2022 Enlarged liver and spleen, erosion of long</li><li>\u2022 bones, mental retardation</li><li>\u2022 no cherry red spot</li><li>\u2022 Option C: Tay-Sachs disease: Due to deficiency of enzyme Hexosaminidase Options A. C/F: Mental retardation, Cherry red spot in the macula and progressive deterioration.</li><li>\u2022 Option C: Tay-Sachs disease:</li><li>\u2022 deficiency</li><li>\u2022 Hexosaminidase</li><li>\u2022 Options A.</li><li>\u2022 Mental retardation, Cherry red spot</li><li>\u2022 macula and progressive deterioration.</li><li>\u2022 Option D: Sandhoff\u2019s disease: Due to deficiency of Hexosaminidase Options A and Options  B , c/f: Neurological deficit and MR with cherry red spot.</li><li>\u2022 Option D: Sandhoff\u2019s disease:</li><li>\u2022 deficiency of Hexosaminidase Options A</li><li>\u2022 Options  B</li><li>\u2022 Neurological deficit and MR</li><li>\u2022 cherry red spot.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Niemann-Pick disease is associated with sphingomyelinase deficiency , leading to the accumulation of sphingomyelin in cells and tissues . The child's symptoms, including developmental delay, hepatosplenomegaly, difficulty walking, falls, seizures, and findings of lipid-laden foam histiocytes on bone marrow biopsy, are characteristic of this disorder.</li><li>\u27a4 Niemann-Pick disease</li><li>\u27a4 sphingomyelinase deficiency</li><li>\u27a4 sphingomyelin in cells</li><li>\u27a4 tissues</li><li>\u27a4 developmental delay, hepatosplenomegaly,</li><li>\u27a4 difficulty walking,</li><li>\u27a4 falls, seizures,</li><li>\u27a4 lipid-laden foam histiocytes</li><li>\u27a4 bone marrow</li><li>\u27a4 biopsy,</li><li>\u27a4 Ref : Harper 30/e: p 68,251.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e: p 68,251.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "56c5be0c",
      "audio": ""
    },
    {
      "text": "A 6-year-old child is brought to the pediatric clinic by his parents, who report that he has been experiencing unusual fatigue, frequent bruising, and episodes of bone pain over the last few months. The child has also been less active than usual, preferring to sit rather than play with his peers. On examination, the pediatrician notes pallor, and palpation reveals an enlarged liver and spleen. A complete blood count confirms anemia and thrombocytopenia. A bone marrow biopsy is performed, and light microscopy of the sample shows cells with a \"crumpled tissue paper\" appearance. Given these findings, which enzyme defect is most likely responsible for this child's condition?",
      "options": [
        {
          "label": "A",
          "text": "Glucocerebrosidase",
          "correct": true
        },
        {
          "label": "B",
          "text": "Sphingomyelinase",
          "correct": false
        },
        {
          "label": "C",
          "text": "Hexosaminidase A",
          "correct": false
        },
        {
          "label": "D",
          "text": "Beta-galactosidase",
          "correct": false
        }
      ],
      "correct_answer": "A. Glucocerebrosidase",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B: Sphingomyelinase : Deficiency of sphingomyelinase is associated with Niemann-Pick disease , which also presents with hepatosplenomegaly but typically includes neurological symptoms due to the accumulation of sphingomyelin in neurons, which is not indicated in this scenario.</li><li>\u2022 Option B: Sphingomyelinase</li><li>\u2022 Deficiency of sphingomyelinase</li><li>\u2022 Niemann-Pick disease</li><li>\u2022 presents</li><li>\u2022 hepatosplenomegaly</li><li>\u2022 neurological symptoms</li><li>\u2022 accumulation of sphingomyelin in neurons,</li><li>\u2022 not</li><li>\u2022 scenario.</li><li>\u2022 Option C: Hexosaminidase A : Deficiency in Hexosaminidase A enzyme is related to Tay-Sachs disease, which primarily presents with progressive neurological symptoms due to the accumulation of GM2 ganglioside in the neuronal cells, not the features described in the presented case.</li><li>\u2022 Option C: Hexosaminidase A</li><li>\u2022 Deficiency in Hexosaminidase A enzyme</li><li>\u2022 Tay-Sachs disease,</li><li>\u2022 progressive neurological symptoms</li><li>\u2022 GM2 ganglioside</li><li>\u2022 neuronal cells,</li><li>\u2022 not</li><li>\u2022 presented case.</li><li>\u2022 Option D: Beta-galactosidase : A deficiency in this enzyme leads to GM1 gangliosidosis, which includes severe neurological impairment and skeletal abnormalities in its presentation, distinct from the scenario described.</li><li>\u2022 Option D: Beta-galactosidase</li><li>\u2022 deficiency</li><li>\u2022 GM1 gangliosidosis,</li><li>\u2022 severe neurological</li><li>\u2022 impairment and skeletal abnormalities</li><li>\u2022 presentation, distinct from</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The clinical presentation of Gaucher's disease , a lysosomal storage disorder caused by a deficiency of the enzyme glucocerebrosidase</li><li>\u27a4 clinical presentation</li><li>\u27a4 Gaucher's disease</li><li>\u27a4 lysosomal storage disorder</li><li>\u27a4 deficiency</li><li>\u27a4 glucocerebrosidase</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 260, 261</li><li>\u27a4 Ref</li><li>\u27a4 : DM Vasudevan 9/e: p 260, 261</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "272fc7ad",
      "audio": ""
    },
    {
      "text": "I-cell disease is characterized by a severe lysosomal storage disorder with symptoms manifesting early in life, including developmental delay, skeletal abnormalities, and coarse facial features. This condition results from a deficiency in a key enzyme necessary for the proper targeting of lysosomal enzymes. Without this enzyme, lysosomal proteins fail to be correctly trafficked to lysosomes. Which of the following recognition markers is not properly formed due to the deficiency of the phosphorylating enzyme in I-cell disease?",
      "options": [
        {
          "label": "A",
          "text": "GM2 ganglioside",
          "correct": false
        },
        {
          "label": "B",
          "text": "Mannose 6-phosphate",
          "correct": true
        },
        {
          "label": "C",
          "text": "Galactocerebroside",
          "correct": false
        },
        {
          "label": "D",
          "text": "Globoside",
          "correct": false
        }
      ],
      "correct_answer": "B. Mannose 6-phosphate",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: GM2 ganglioside : This is a component of neuronal cell membranes and is accumulated in Tay-Sachs disease , not I-cell disease, due to a deficiency in Hexosaminidase A, an enzyme unrelated to the defect in I-cell disease.</li><li>\u2022 Option A: GM2 ganglioside</li><li>\u2022 component of neuronal cell membranes</li><li>\u2022 Tay-Sachs disease</li><li>\u2022 not I-cell</li><li>\u2022 disease,</li><li>\u2022 deficiency in Hexosaminidase A,</li><li>\u2022 unrelated to the defect in I-cell disease.</li><li>\u2022 Option C: Galactocerebroside : This is a major component of myelin sheath in the nervous system . Accumulation of galactocerebroside due to a deficiency of galactocerebrosidase enzyme is seen in Krabbe disease , not I-cell disease.</li><li>\u2022 Option C: Galactocerebroside</li><li>\u2022 major</li><li>\u2022 myelin sheath in the nervous system</li><li>\u2022 Accumulation</li><li>\u2022 galactocerebroside</li><li>\u2022 deficiency of galactocerebrosidase</li><li>\u2022 Krabbe disease</li><li>\u2022 Option D: Globoside : Accumulation of globosides occurs in Fabry disease due to a deficiency in alpha-galactosidase A, which is not related to the enzyme deficiency observed in I-cell disease.</li><li>\u2022 Option D: Globoside</li><li>\u2022 Accumulation of globosides</li><li>\u2022 Fabry disease</li><li>\u2022 deficiency in alpha-galactosidase A,</li><li>\u2022 not</li><li>\u2022 I-cell disease.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Inclusion cell (I-cell) disease is a condition in which lysosomes lack in enzymes but are seen in blood. Mannose-6-phosphate is the marker enzyme to target the nascent enzymes to lysosomes. In I CELL DISEASE, the carbohydrate units are not added to the enzyme \u2192 Mannose-6-phosphate deficient enzymes cannot reach their destination ( protein targeting defect ).</li><li>\u27a4 Inclusion cell (I-cell) disease is a condition in which lysosomes lack in enzymes but are seen in blood.</li><li>\u27a4 Inclusion cell (I-cell) disease</li><li>\u27a4 lysosomes lack in enzymes</li><li>\u27a4 seen in blood.</li><li>\u27a4 Mannose-6-phosphate is the marker enzyme to target the nascent enzymes to lysosomes.</li><li>\u27a4 Mannose-6-phosphate</li><li>\u27a4 marker enzyme</li><li>\u27a4 nascent enzymes to lysosomes.</li><li>\u27a4 In I CELL DISEASE, the carbohydrate units are not added to the enzyme \u2192 Mannose-6-phosphate deficient enzymes cannot reach their destination ( protein targeting defect ).</li><li>\u27a4 I CELL DISEASE,</li><li>\u27a4 not</li><li>\u27a4 Mannose-6-phosphate deficient</li><li>\u27a4 cannot</li><li>\u27a4 protein targeting defect</li><li>\u27a4 Ref : Harper 30/e p586</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e p586</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "cf2f7853",
      "audio": ""
    },
    {
      "text": "Based on the clinical presentation (as shown in image), which of the following is the most probable diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Familial Chylomicronemia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Familial Hypercholesterolemia",
          "correct": true
        },
        {
          "label": "C",
          "text": "Abetalipoproteinemia",
          "correct": false
        },
        {
          "label": "D",
          "text": "Broad Beta Disease",
          "correct": false
        }
      ],
      "correct_answer": "B. Familial Hypercholesterolemia",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/10/1_BiC30gi.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: Familial Chylomicronemia: C/F- Hepatomegaly, eruptive xanthoma and abdominal pain.</li><li>\u2022 Option A: Familial Chylomicronemia:</li><li>\u2022 Hepatomegaly, eruptive xanthoma and abdominal pain.</li><li>\u2022 Option C: Abetalipoproteinemia: Low levels of serum triglycerides, cholesterol and phospholipids . C/F- Blindness due to degenerative changes in retina and spiny projections in erythrocytes (acanthocytes).</li><li>\u2022 Option C: Abetalipoproteinemia:</li><li>\u2022 Low levels of serum triglycerides,</li><li>\u2022 cholesterol and phospholipids</li><li>\u2022 Blindness</li><li>\u2022 degenerative changes</li><li>\u2022 retina</li><li>\u2022 spiny projections</li><li>\u2022 erythrocytes (acanthocytes).</li><li>\u2022 Option D: Broad Beta Disease: Palmar xanthoma and increased risk for vascular disease.</li><li>\u2022 Option D: Broad Beta Disease:</li><li>\u2022 Palmar xanthoma</li><li>\u2022 increased risk for vascular disease.</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 Familial Hypercholesterolemia is characterized by high LDL cholesterol levels and the presence of xanthomas , which are deposits of cholesterol in the skin and tendons , due to a genetic defect in LDL receptors.</li><li>\u2022 Familial Hypercholesterolemia</li><li>\u2022 high LDL cholesterol levels</li><li>\u2022 xanthomas</li><li>\u2022 cholesterol in the skin and tendons</li><li>\u2022 genetic defect in LDL receptors.</li><li>\u2022 Ref : Vasudevan 9 /ed: P245, 246.</li><li>\u2022 Ref</li><li>\u2022 : Vasudevan 9 /ed: P245, 246.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "7de7e314",
      "audio": ""
    },
    {
      "text": "A 45-year-old man with established coronary artery disease returns with new complaints of numbness in his hands and feet. On examination, below finding is observed. His lipid panel reveals HDL cholesterol levels are markedly low. What is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Hypo alpha lipoproteinemia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Tangier Disease",
          "correct": true
        },
        {
          "label": "C",
          "text": "Familial alpha Lp-deficiency",
          "correct": false
        },
        {
          "label": "D",
          "text": "Hyper alpha lipoproteinemia",
          "correct": false
        }
      ],
      "correct_answer": "B. Tangier Disease",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/10/2_T4chRaU.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Tangier Disease</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: Hypo alpha lipoproteinemia: Here serum HDL is decreased \u2192 High risk for coronary artery diseases.</li><li>\u2022 Option A: Hypo alpha lipoproteinemia:</li><li>\u2022 HDL is decreased</li><li>\u2022 High risk for coronary artery diseases.</li><li>\u2022 Option C: Familial alpha Lp-deficiency: Have \u2193\u2193HDL and A-l, Normal- Cholesterol and TAG \u2192 Increased risk of CAD.</li><li>\u2022 Option C: Familial alpha Lp-deficiency:</li><li>\u2022 \u2193\u2193HDL and A-l, Normal- Cholesterol and TAG</li><li>\u2022 Increased risk of CAD.</li><li>\u2022 Option D: Hyper alpha lipoproteinemia: Increased HDL and is a rare condition apparently beneficial to health.</li><li>\u2022 Option D: Hyper alpha lipoproteinemia:</li><li>\u2022 Increased HDL</li><li>\u2022 rare</li><li>\u2022 beneficial to health.</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 Tangier disease by its classic presentation of orange-yellow tonsillar hypertrophy, neuropathy, and low HDL levels.</li><li>\u2022 Tangier disease</li><li>\u2022 orange-yellow tonsillar hypertrophy, neuropathy, and low HDL levels.</li><li>\u2022 Ref : Lippincott 7/e: P 236</li><li>\u2022 Ref</li><li>\u2022 : Lippincott 7/e: P 236</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "2344f5ae",
      "audio": ""
    },
    {
      "text": "In an electrophoretic separation procedure, a technician observes the migration of lipoproteins from the cathode (-) to the anode (+) sidewhich of the following correctly orders the lipoproteins from cathode to anode?",
      "options": [
        {
          "label": "A",
          "text": "CM > LDL > VLDL > HDL",
          "correct": true
        },
        {
          "label": "B",
          "text": "CM > VLDL > LDL > HDL",
          "correct": false
        },
        {
          "label": "C",
          "text": "HDL > VLDL > LDL > CM",
          "correct": false
        },
        {
          "label": "D",
          "text": "HDL > VLDL > LDL > CM",
          "correct": false
        }
      ],
      "correct_answer": "A. CM > LDL > VLDL > HDL",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/10/4_03T9YxQ.jpg"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/Picture3_cTaOOJy.png"
      ],
      "explanation": "<p><strong>Ans. A)\u00a0CM > LDL > VLDL > HDL</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Lipoprotein electrophoresis separates particles based on their protein content and charge. Understanding the typical migration pattern helps diagnose dyslipidemias and distinguish between different lipoprotein abnormalities.</li><li>\u27a4 protein content and charge.</li><li>\u27a4 Ref : Lippincott 7/e: 228.</li><li>\u27a4 Ref</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e74661cd",
      "audio": ""
    },
    {
      "text": "A 36-year-old man who consumes a fat-free, high-carbohydrate diet finds that he continues to gain weight. Considering the dietary influence on lipoprotein metabolism, which apoprotein is most likely to be elevated in his blood?",
      "options": [
        {
          "label": "A",
          "text": "Chylomicrons",
          "correct": false
        },
        {
          "label": "B",
          "text": "HDL",
          "correct": false
        },
        {
          "label": "C",
          "text": "LDL",
          "correct": false
        },
        {
          "label": "D",
          "text": "VLDL",
          "correct": true
        }
      ],
      "correct_answer": "D. VLDL",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: Chylomicrons: Carry TAG from gut to muscle and adipose tissue</li><li>\u2022 Option A: Chylomicrons:</li><li>\u2022 TAG</li><li>\u2022 gut</li><li>\u2022 muscle and adipose tissue</li><li>\u2022 Option B: HDL: Carry cholesterol from peripheral tissues to liver</li><li>\u2022 Option B: HDL:</li><li>\u2022 cholesterol</li><li>\u2022 peripheral tissues to liver</li><li>\u2022 Option C: LDL: Carry cholesterol from liver to peripheral tissues</li><li>\u2022 Option C: LDL:</li><li>\u2022 cholesterol</li><li>\u2022 liver to peripheral tissues</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 A fat-free, high-carbohydrate diet can lead to increased synthesis of VLDL (Very Low-Density Lipoprotein) in the liver. VLDL is responsible for transporting endogenously synthesized triglycerides , which the body produces from excess carbohydrates, to adipose tissue for storage . This could contribute to ongoing obesity despite the absence of dietary fat.</li><li>\u27a4 fat-free, high-carbohydrate diet</li><li>\u27a4 increased synthesis of VLDL</li><li>\u27a4 liver.</li><li>\u27a4 VLDL</li><li>\u27a4 transporting endogenously synthesized triglycerides</li><li>\u27a4 body produces</li><li>\u27a4 excess carbohydrates,</li><li>\u27a4 adipose tissue</li><li>\u27a4 storage</li><li>\u27a4 ongoing obesity</li><li>\u27a4 absence of dietary fat.</li><li>\u27a4 Ref : Harper 30/e: p 255-257.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e: p 255-257.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d95c4425",
      "audio": ""
    },
    {
      "text": "A 50-year-old male with a familial history of increased cholesterol levels presents with an isolated elevation in LDL. His father and brother had similar lipid abnormalities. Given the isolated increase in LDL and family history, what is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Familial type III hyperlipoproteinemia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Abetalipoproteinemia",
          "correct": false
        },
        {
          "label": "C",
          "text": "LDL receptor mutation",
          "correct": true
        },
        {
          "label": "D",
          "text": "Familial LPL deficiency (type l)",
          "correct": false
        }
      ],
      "correct_answer": "C. LDL receptor mutation",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: Familial type llI hyperlipoproteinemia: due to the abnormality in apoE , remnant clearance by the liver is defective resulting in increased levels of chylomicron and VLDL remnants. It can cause hypercholesterolemia, atherosclerosis, and xanthomas.</li><li>\u2022 Option A: Familial type llI hyperlipoproteinemia:</li><li>\u2022 abnormality</li><li>\u2022 apoE</li><li>\u2022 clearance</li><li>\u2022 liver is defective</li><li>\u2022 in increased levels of chylomicron and VLDL remnants.</li><li>\u2022 hypercholesterolemia, atherosclerosis, and xanthomas.</li><li>\u2022 Option B: Abetalipoproteinemia: Defective loading of apo B with lipid \u2192 absence of formation of chylomicrons, VLDL or LDL , low blood acylglycerols with accumulation of it in the intestine and liver.</li><li>\u2022 Option B: Abetalipoproteinemia:</li><li>\u2022 Defective</li><li>\u2022 apo B</li><li>\u2022 absence of formation of chylomicrons, VLDL or LDL</li><li>\u2022 low</li><li>\u2022 blood acylglycerols</li><li>\u2022 intestine and liver.</li><li>\u2022 Option D: Familial LPL deficiency (type l): Due to deficiency of LPL or abnormal LPL or apo C-ll deficiency \u2192 Hypertriacylglycerolemia with slow clearance of chylomicrons and VLDL, low levels of LDL and HDL.</li><li>\u2022 Option D: Familial LPL deficiency (type l):</li><li>\u2022 Due to deficiency</li><li>\u2022 LPL or abnormal LPL or apo C-ll deficiency</li><li>\u2022 Hypertriacylglycerolemia</li><li>\u2022 low levels of LDL and HDL.</li><li>\u2022 Educational objective :</li><li>\u2022 Educational objective</li><li>\u2022 LDL receptor gene mutation is characterized by isolated elevated LDL cholesterol levels and a family history of hypercholesterolemia and early cardiovascular disease.</li><li>\u2022 LDL receptor</li><li>\u2022 isolated elevated LDL cholesterol levels</li><li>\u2022 family history of hypercholesterolemia</li><li>\u2022 cardiovascular disease.</li><li>\u2022 Ref : Harper 30/e:  p 275,276.</li><li>\u2022 Ref</li><li>\u2022 : Harper 30/e:  p 275,276.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "dfb257c3",
      "audio": ""
    },
    {
      "text": "Three hours after a healthy middle-aged man eats a meal that includes carbohydrates, proteins, and fats, a blood sample is drawn to assess his lipid profile. Considering normal digestive physiology and the timing of the sample in relation to his meal, which component in his blood is likely to be elevated at this point?",
      "options": [
        {
          "label": "A",
          "text": "Fatty acids",
          "correct": false
        },
        {
          "label": "B",
          "text": "Glucagon",
          "correct": false
        },
        {
          "label": "C",
          "text": "Glycerol",
          "correct": false
        },
        {
          "label": "D",
          "text": "Chylomicrons",
          "correct": true
        }
      ],
      "correct_answer": "D. Chylomicrons",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: Fatty acids : Fatty acids in the blood usually increase during fasting when fat stores are mobilized for energy, not postprandially.</li><li>\u2022 Option A: Fatty acids</li><li>\u2022 blood</li><li>\u2022 increase during fasting</li><li>\u2022 fat stores</li><li>\u2022 energy,</li><li>\u2022 Option B: Glucagon : Glucagon levels typically rise during fasting to promote glucose production and release by the liver, not after a meal when insulin is the predominant hormone.</li><li>\u2022 Option B: Glucagon</li><li>\u2022 rise during fasting</li><li>\u2022 promote glucose production</li><li>\u2022 liver, not</li><li>\u2022 meal</li><li>\u2022 insulin is the predominant hormone.</li><li>\u2022 Option C: Glycerol : Glycerol levels in the blood typically increase during triglyceride breakdown , which occurs during fasting or exercise, not postprandially.</li><li>\u2022 Option C: Glycerol</li><li>\u2022 Glycerol</li><li>\u2022 blood</li><li>\u2022 increase during triglyceride breakdown</li><li>\u2022 during fasting</li><li>\u2022 exercise,</li><li>\u2022 not postprandially.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The postprandial rise in chylomicron levels in response to a well-balanced meal , reflecting the normal physiological process of dietary fat transport.</li><li>\u27a4 postprandial rise in chylomicron levels</li><li>\u27a4 well-balanced meal</li><li>\u27a4 normal physiological process</li><li>\u27a4 dietary fat transport.</li><li>\u27a4 Ref : Harper 30/e:  p 257-259.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e:  p 257-259.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b46c0458",
      "audio": ""
    },
    {
      "text": "In a clinical study examining lipid metabolism disorders, researchers observe participants with markedly elevated plasma levels of chylomicrons and triacylglycerols. Which type of hyperlipoproteinemia is most consistent with these findings?",
      "options": [
        {
          "label": "A",
          "text": "Type I hyperlipoproteinemia",
          "correct": true
        },
        {
          "label": "B",
          "text": "Type IV hyperlipoproteinemia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Type IIb hyperlipoproteinemia",
          "correct": false
        },
        {
          "label": "D",
          "text": "Type V hyperlipoproteinemia",
          "correct": false
        }
      ],
      "correct_answer": "A. Type I hyperlipoproteinemia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B: Familial Endogenous type - due to over production of TG by liver, elevated VLDL level \u2192 Cardiac manifestations. Associated with DM, obesity and impaired glucose tolerance.</li><li>\u2022 Option B:</li><li>\u2022 Familial Endogenous type</li><li>\u2022 over production of TG</li><li>\u2022 elevated VLDL level</li><li>\u2022 Cardiac manifestations.</li><li>\u2022 DM, obesity and impaired glucose tolerance.</li><li>\u2022 Option C: Elevation of both CHL and TG with excessive production of apo-B \u2192 elevated LDL and VLDL.</li><li>\u2022 Option C:</li><li>\u2022 Elevation</li><li>\u2022 both CHL and TG</li><li>\u2022 excessive production of apo-B</li><li>\u2022 elevated LDL and VLDL.</li><li>\u2022 Option D: Elevated CM and VLDL. Hypertriglyceridemia secondary to disorders like obesity, excessive alcohol intake, renal failure, pancreatitis , etc. are common. Other causes: hepatic lipase defect, LCAT defect and Lp(a) excess and Wolman\u2019s disease</li><li>\u2022 Option D:</li><li>\u2022 Elevated CM and VLDL. Hypertriglyceridemia</li><li>\u2022 obesity, excessive alcohol intake, renal failure,</li><li>\u2022 pancreatitis</li><li>\u2022 hepatic lipase defect, LCAT defect and Lp(a) excess and Wolman\u2019s disease</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Type I hyperlipoproteinemia , also known as familial lipoprotein lipase deficiency, is characterized by markedly elevated plasma levels of chylomicrons due to a deficiency of lipoprotein lipase or its cofactor apolipoprotein C-II. This leads to an inability to hydrolyze the triglycerides carried by chylomicrons , resulting in high levels of both chylomicrons and triglycerides in the plasma.</li><li>\u27a4 Type I hyperlipoproteinemia</li><li>\u27a4 familial lipoprotein lipase deficiency,</li><li>\u27a4 markedly elevated plasma</li><li>\u27a4 levels of chylomicrons</li><li>\u27a4 deficiency of lipoprotein lipase</li><li>\u27a4 cofactor apolipoprotein C-II.</li><li>\u27a4 inability to</li><li>\u27a4 hydrolyze</li><li>\u27a4 triglycerides</li><li>\u27a4 chylomicrons</li><li>\u27a4 high levels of both chylomicrons and triglycerides in the plasma.</li><li>\u27a4 Ref : Vasudevan 9 /ed: p245, 246.</li><li>\u27a4 Ref</li><li>\u27a4 : Vasudevan 9 /ed: p245, 246.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b0349a24",
      "audio": ""
    },
    {
      "text": "A 45-year-old woman undergoes routine health screening, including a lipid profile, while fasting. Her results show a total cholesterol of 300 mg/dL, HDL cholesterol of 25 mg/dL, and triglycerides of 150 mg/dL. Utilizing the Friedewald equation to assess her cardiovascular risk, what is the LDL cholesterol level in this patient?",
      "options": [
        {
          "label": "A",
          "text": "245 mg/dl",
          "correct": true
        },
        {
          "label": "B",
          "text": "135 mg/dl",
          "correct": false
        },
        {
          "label": "C",
          "text": "85 mg/dl",
          "correct": false
        },
        {
          "label": "D",
          "text": "45 mg/dl",
          "correct": false
        }
      ],
      "correct_answer": "A. 245 mg/dl",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A)</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "bcf900cb",
      "audio": ""
    },
    {
      "text": "A 50-year-old man with coronary artery disease (CAD) is being successfully treated with anti-atherogenic medication that targets PCSK9. Following treatment, his lipid profile normalizes, and his cardiac status improves. What is the primary function of PCSK9?",
      "options": [
        {
          "label": "A",
          "text": "Increasing the synthesis and secretion of VLDL from liver resulting in high LDL levels in the blood",
          "correct": false
        },
        {
          "label": "B",
          "text": "Inhibiting the binding of apoB to LDL receptor, thereby blocking the lipoprotein uptake and increasing the blood cholesterol levels",
          "correct": false
        },
        {
          "label": "C",
          "text": "Decreasing the availability of LDL receptors on the cell surface, resulting in decreased LDL uptake and high blood cholesterol level",
          "correct": true
        },
        {
          "label": "D",
          "text": "Preventing the cholesterol breakdown into bile acids in the liver",
          "correct": false
        }
      ],
      "correct_answer": "C. Decreasing the availability of LDL receptors on the cell surface, resulting in decreased LDL uptake and high blood cholesterol level",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Decreasing the availability of LDL receptors on the cell surface, resulting in decreased LDL uptake and high blood cholesterol level</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Understanding that PCSK9 inhibitors work by preventing PCSK9-mediated degradation of LDL receptors, thereby increasing LDL receptor availability, enhancing LDL cholesterol clearance, and lowering blood cholesterol levels in patients with coronary artery disease.</li><li>\u27a4 Ref : Harper 30/e:  p 271, 275, 278-279.</li><li>\u27a4 Ref</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6f8e5499",
      "audio": ""
    },
    {
      "text": "In an experiment, a team of scientists incubates liver cells at 0\u00b0C and treats them with trypsin to digest surface receptors. The temperature is then increased to 37\u00b0C, and radioactive LDL is introduced to the culture. Subsequently, the labelled LDL is found inside the liver cells. What is the process responsible for the internalization of LDL called?",
      "options": [
        {
          "label": "A",
          "text": "Facilitated diffusion",
          "correct": false
        },
        {
          "label": "B",
          "text": "Pinocytosis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Phagocytosis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Receptor-mediated endocytosis",
          "correct": true
        }
      ],
      "correct_answer": "D. Receptor-mediated endocytosis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: Facilitated diffusion: Is the transport of low-permeability molecules with the aid of a carrier protein.</li><li>\u2022 Option A: Facilitated diffusion:</li><li>\u2022 low-permeability molecules</li><li>\u2022 carrier protein.</li><li>\u2022 Option B: Pinocytosis: Uptake of small molecules in solution , is receptor \u2013independent.</li><li>\u2022 Option B: Pinocytosis:</li><li>\u2022 small molecules in solution</li><li>\u2022 receptor \u2013independent.</li><li>\u2022 Option C: Phagocytosis: Process by which cells such as macrophages and neutrophils engulf large particles.</li><li>\u2022 Option C: Phagocytosis:</li><li>\u2022 cells</li><li>\u2022 macrophages and neutrophils engulf large particles.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Receptor-mediated endocytosis is the specific and efficient mechanism by which LDL is internalized by liver cells, involving the interaction of LDL with cell surface LDL receptors.</li><li>\u27a4 Receptor-mediated endocytosis</li><li>\u27a4 specific and efficient</li><li>\u27a4 LDL is internalized by liver cells,</li><li>\u27a4 LDL with cell surface LDL receptors.</li><li>\u27a4 Ref : Harper 30/e: p 257-258.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e: p 257-258.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c27c2a70",
      "audio": ""
    },
    {
      "text": "A patient with coronary artery disease (CAD), currently undergoing treatment, is advised to implement lifestyle modifications and monitor his lipid profile quarterly. Among the lipoproteins evaluated, which one is characterized by the lowest lipid-to-protein ratio?",
      "options": [
        {
          "label": "A",
          "text": "Chylomicrons",
          "correct": false
        },
        {
          "label": "B",
          "text": "VLDL",
          "correct": false
        },
        {
          "label": "C",
          "text": "HDL",
          "correct": true
        },
        {
          "label": "D",
          "text": "LDL",
          "correct": false
        }
      ],
      "correct_answer": "C. HDL",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/18/screenshot-2024-04-18-182641.png"
      ],
      "explanation": "<p><strong>Ans. C)</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Among different HDL particles , percentage of lipids seen will be:</li><li>\u27a4 different HDL particles</li><li>\u27a4 percentage of lipids</li><li>\u27a4 HDL 1 : 65%</li><li>\u27a4 HDL2  : 67%</li><li>\u27a4 HDL3  : 43%</li><li>\u27a4 Pre\u03b2-HDL : 30</li><li>\u27a4 Ref : Harper 30/e: p 478-479, 484.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e: p 478-479, 484.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "bca38203",
      "audio": ""
    },
    {
      "text": "A 25-year-old student has been experiencing yellowish discoloration of the palms for the past seven months, with no changes in sclera or mucous membranes and no history of chemical exposure. His lipid profile shows the below results: Laboratory investigations: Total cholesterol: 240 mg/dl (N = < 200 mg/dl) LDL cholesterol: 145 mg/dl (N = < 100 mg/dl) TG: 250 mg/dl (N = 60-150 mg/dl) HDL cholesterol: 45 mg/dl (N = 40-75 mg/dl) Lipoprotein electrophoresis shows a broad beta band. Given these findings, what is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Familial Chylomicronemia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Type III Hyperlipoproteinemia",
          "correct": true
        },
        {
          "label": "C",
          "text": "Abetalipoproteinemia",
          "correct": false
        },
        {
          "label": "D",
          "text": "Type IIa Hyperlipoproteinemia",
          "correct": false
        }
      ],
      "correct_answer": "B. Type III Hyperlipoproteinemia",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/10/8_IvdwEdI.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Type III Hyperlipoproteinemia</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Type III Hyperlipoproteinemia , also known as dysbetalipoproteinemia or broad beta disease , is caused by a defect in apolipoprotein E (apoE) , which impairs the clearance of chylomicron remnants and IDL from the plasma.</li><li>\u2022 Type III Hyperlipoproteinemia</li><li>\u2022 dysbetalipoproteinemia</li><li>\u2022 broad beta disease</li><li>\u2022 apolipoprotein E (apoE)</li><li>\u2022 chylomicron remnants and IDL</li><li>\u2022 Key features include:</li><li>\u2022 Key features include:</li><li>\u2022 Elevated total cholesterol and triglycerides (typically both increased) Broad beta band on electrophoresis , due to accumulation of remnant lipoproteins Palmar xanthomas \u2014 yellowish discoloration or deposits in the creases of the palms Increased risk of premature atherosclerosis</li><li>\u2022 Elevated total cholesterol and triglycerides (typically both increased)</li><li>\u2022 Elevated total cholesterol and triglycerides</li><li>\u2022 Broad beta band on electrophoresis , due to accumulation of remnant lipoproteins</li><li>\u2022 Broad beta band on electrophoresis</li><li>\u2022 Palmar xanthomas \u2014 yellowish discoloration or deposits in the creases of the palms</li><li>\u2022 Palmar xanthomas</li><li>\u2022 Increased risk of premature atherosclerosis</li><li>\u2022 Increased risk of premature atherosclerosis</li><li>\u2022 This patient\u2019s lipid pattern , broad beta band , and palmar discoloration (xanthomas) are classic for Type III Hyperlipoproteinemia .</li><li>\u2022 lipid pattern</li><li>\u2022 broad beta band</li><li>\u2022 palmar discoloration</li><li>\u2022 Type III Hyperlipoproteinemia</li><li>\u2022 Other Options:</li><li>\u2022 Other Options:</li><li>\u2022 Option A. Familial Chylomicronemia (Type I) \u2013 Presents with very high triglycerides , creamy plasma , and eruptive xanthomas , usually without a broad beta band. Option C. Abetalipoproteinemia \u2013 Features very low or absent apoB-containing lipoproteins , leading to low cholesterol and triglycerides , fat malabsorption , and acanthocytosis . Not seen here. Option D. Type IIa Hyperlipoproteinemia (Familial Hypercholesterolemia) \u2013 Characterized by isolated elevated LDL , normal triglycerides , and tendon xanthomas . Not compatible with this lipid profile.</li><li>\u2022 Option A. Familial Chylomicronemia (Type I) \u2013 Presents with very high triglycerides , creamy plasma , and eruptive xanthomas , usually without a broad beta band.</li><li>\u2022 Option A. Familial Chylomicronemia (Type I)</li><li>\u2022 very high triglycerides</li><li>\u2022 creamy plasma</li><li>\u2022 eruptive xanthomas</li><li>\u2022 Option C. Abetalipoproteinemia \u2013 Features very low or absent apoB-containing lipoproteins , leading to low cholesterol and triglycerides , fat malabsorption , and acanthocytosis . Not seen here.</li><li>\u2022 Option C. Abetalipoproteinemia</li><li>\u2022 very low or absent apoB-containing lipoproteins</li><li>\u2022 low cholesterol and triglycerides</li><li>\u2022 fat malabsorption</li><li>\u2022 acanthocytosis</li><li>\u2022 Option D. Type IIa Hyperlipoproteinemia (Familial Hypercholesterolemia) \u2013 Characterized by isolated elevated LDL , normal triglycerides , and tendon xanthomas . Not compatible with this lipid profile.</li><li>\u2022 Option D. Type IIa Hyperlipoproteinemia (Familial Hypercholesterolemia)</li><li>\u2022 isolated elevated LDL</li><li>\u2022 normal triglycerides</li><li>\u2022 tendon xanthomas</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Recognize Type III Hyperlipoproteinemia by its unique clinical features:</li><li>\u27a4 Type III Hyperlipoproteinemia</li><li>\u27a4 Combined elevation of cholesterol and triglycerides Broad beta band on electrophoresis Palmar xanthomas</li><li>\u27a4 Combined elevation of cholesterol and triglycerides</li><li>\u27a4 Broad beta band on electrophoresis</li><li>\u27a4 Broad beta band</li><li>\u27a4 Palmar xanthomas</li><li>\u27a4 Palmar xanthomas</li><li>\u27a4 Ref : Vasudevan 9 /ed: p245, 246.</li><li>\u27a4 Ref</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d951934d",
      "audio": ""
    },
    {
      "text": "Among the listed apolipoproteins, which one serves as an activator for Lecithin Cholesterol Acyltransferase (LCAT), an enzyme critical in the process of cholesterol esterification within high-density lipoprotein (HDL) particles?",
      "options": [
        {
          "label": "A",
          "text": "Apo B-100",
          "correct": false
        },
        {
          "label": "B",
          "text": "Apo B-48",
          "correct": false
        },
        {
          "label": "C",
          "text": "Apo A-II",
          "correct": false
        },
        {
          "label": "D",
          "text": "Apo A-I",
          "correct": true
        }
      ],
      "correct_answer": "D. Apo A-I",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/19/screenshot-2024-04-19-101017.png"
      ],
      "explanation": "<p><strong>Ans. D)</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 INHIBITOR OF ENZYMES: CI inhibits CETP , A-II, C-III inhibits LPL</li><li>\u27a4 INHIBITOR</li><li>\u27a4 CI</li><li>\u27a4 CETP</li><li>\u27a4 A-II, C-III</li><li>\u27a4 LPL</li><li>\u27a4 ACTIVATOR OF ENZYMES: A-I activates LCAT , C-I, II activates LPL</li><li>\u27a4 ACTIVATOR</li><li>\u27a4 A-I</li><li>\u27a4 LCAT</li><li>\u27a4 C-I, II</li><li>\u27a4 LPL</li><li>\u27a4 Ref : Harper 30/ed, pg -272.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/ed, pg -272.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d853e8e3",
      "audio": ""
    },
    {
      "text": "A molecular biologist is explaining to a group of students the unique process through which Apo B48 is produced in the body. This protein is essential for the formation of chylomicrons, which transport dietary lipids from the intestines to other parts of the body. By what mechanism is Apo B48 generated?",
      "options": [
        {
          "label": "A",
          "text": "RNA alternate splicing",
          "correct": false
        },
        {
          "label": "B",
          "text": "RNA editing",
          "correct": true
        },
        {
          "label": "C",
          "text": "DNA editing",
          "correct": false
        },
        {
          "label": "D",
          "text": "RNA interference",
          "correct": false
        }
      ],
      "correct_answer": "B. RNA editing",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/19/screenshot-2024-04-19-103140.png"
      ],
      "explanation": "<p><strong>Ans. B)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: RNA alternate splicing : This process involves the removal or inclusion of segments of the pre-mRNA transcript , leading to the production of different mRNA variants and, consequently , different proteins from the same gene. However, it is not the mechanism by which Apo B48 is produced.</li><li>\u2022 Option A: RNA alternate splicing</li><li>\u2022 removal or inclusion</li><li>\u2022 pre-mRNA transcript</li><li>\u2022 different mRNA variants</li><li>\u2022 , different proteins from the same gene.</li><li>\u2022 not</li><li>\u2022 Apo B48</li><li>\u2022 Option C: DNA editing : DNA editing refers to direct changes to the DNA sequence itself , which is not applicable in the case of Apo B48 production .</li><li>\u2022 Option C: DNA editing</li><li>\u2022 direct changes to the DNA sequence itself</li><li>\u2022 not</li><li>\u2022 case of Apo B48 production</li><li>\u2022 Option D: RNA interference : RNA interference is a biological process in which RNA molecules inhibit gene expression or translation by neutralizing targeted mRNA molecules. It does not involve the production of Apo B48 .</li><li>\u2022 Option D: RNA interference</li><li>\u2022 biological process</li><li>\u2022 RNA molecules inhibit gene expression or translation by neutralizing targeted mRNA molecules.</li><li>\u2022 does not</li><li>\u2022 Apo B48</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Apo B48 is generated through RNA editing, a post-transcriptional modification that alters the nucleotide sequence of the RNA , resulting in a shorter protein variant crucial for chylomicron formation in the intestines.</li><li>\u27a4 Apo B48</li><li>\u27a4 RNA editing, a post-transcriptional modification</li><li>\u27a4 nucleotide</li><li>\u27a4 RNA</li><li>\u27a4 shorter protein variant</li><li>\u27a4 chylomicron formation in the intestines.</li><li>\u27a4 Ref : Vasudevan 9 /ed: p226.</li><li>\u27a4 Ref</li><li>\u27a4 : Vasudevan 9 /ed: p226.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "907b4f4d",
      "audio": ""
    },
    {
      "text": "A 35-year-old man with abetalipoproteinemia presents with an abnormal blood picture showing acanthocytes, alongside symptoms of hyperkeratosis, acrodermatitis, and hypercholesterolemia. Considering the pathophysiology of abetalipoproteinemia and the patient's symptoms, the abnormal red cell morphology and associated clinical manifestations are most likely due to the malabsorption of which essential nutrient?",
      "options": [
        {
          "label": "A",
          "text": "Ascorbic acid",
          "correct": false
        },
        {
          "label": "B",
          "text": "Folic acid",
          "correct": false
        },
        {
          "label": "C",
          "text": "Arachidonic acid",
          "correct": false
        },
        {
          "label": "D",
          "text": "Linoleic acid",
          "correct": true
        }
      ],
      "correct_answer": "D. Linoleic acid",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D)</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Abetalipoproteinemia is a disorder characterized by the malabsorption and deficiency of fat-soluble vitamins and essential fatty acids , due to the inability to properly synthesize and secrete apolipoprotein B-containing lipoproteins.</li><li>\u27a4 Abetalipoproteinemia</li><li>\u27a4 malabsorption and deficiency of fat-soluble vitamins</li><li>\u27a4 essential fatty</li><li>\u27a4 acids</li><li>\u27a4 inability</li><li>\u27a4 synthesize</li><li>\u27a4 secrete apolipoprotein B-containing lipoproteins.</li><li>\u27a4 Linoleic acid is a polyunsaturated fatty acid crucial for maintaining membrane integrity and function, including that of red blood cells. The deficiency in linoleic acid disrupts normal membrane structure , leading to the formation of acanthocytes.</li><li>\u27a4 Linoleic acid</li><li>\u27a4 polyunsaturated fatty acid</li><li>\u27a4 membrane integrity and function,</li><li>\u27a4 red blood</li><li>\u27a4 cells.</li><li>\u27a4 deficiency in linoleic acid disrupts</li><li>\u27a4 membrane structure</li><li>\u27a4 leading</li><li>\u27a4 acanthocytes.</li><li>\u27a4 Ref : Lippincott 6/e: p 182, 363.</li><li>\u27a4 Ref</li><li>\u27a4 : Lippincott 6/e: p 182, 363.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c83c5d01",
      "audio": ""
    },
    {
      "text": "A physician is consulting a patient about his elevated triglyceride levels. The patient is non-diabetic and has no history of alcohol overuse, factors known to influence triglyceride levels. The physician explains that a certain lipoprotein is primarily responsible for transporting triglycerides synthesized by the liver. Which lipoprotein does the liver use to transport these endogenous triglycerides?",
      "options": [
        {
          "label": "A",
          "text": "Chylomicrons",
          "correct": false
        },
        {
          "label": "B",
          "text": "VLDL",
          "correct": true
        },
        {
          "label": "C",
          "text": "LDL",
          "correct": false
        },
        {
          "label": "D",
          "text": "HDL",
          "correct": false
        }
      ],
      "correct_answer": "B. VLDL",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/19/screenshot-2024-04-19-110237.png"
      ],
      "explanation": "<p><strong>Ans. B) VLDL</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: Chylomicrons : These transport dietary, or exogenous, lipids from the intestines to other tissues in the body after a meal.</li><li>\u2022 Option A: Chylomicrons</li><li>\u2022 transport dietary, or exogenous, lipids</li><li>\u2022 intestines to other tissues</li><li>\u2022 meal.</li><li>\u2022 Option C: LDL : Primarily carries cholesterol to the body's cells rather than triacylglycerol.</li><li>\u2022 Option C: LDL</li><li>\u2022 cholesterol to the body's cells</li><li>\u2022 Option D: HDL : Involved in reverse cholesterol transport, carrying cholesterol from the tissues back to the liver , and is not a primary carrier of triacylglycerol.</li><li>\u2022 Option D: HDL</li><li>\u2022 reverse cholesterol transport,</li><li>\u2022 cholesterol from the tissues back to the liver</li><li>\u2022 not</li><li>\u2022 triacylglycerol.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Ref : Vasudevan 9 /ed: p 226.</li><li>\u27a4 Ref</li><li>\u27a4 : Vasudevan 9 /ed: p 226.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "206e8d49",
      "audio": ""
    },
    {
      "text": "Assertion (A): In well-fed state, activity of acetyl CoA carboxylase activity is increased. Reasoning (R): Citrate produced from acetyl CoA in well-fed state acts as an allosteric activator of acetyl CoA carboxylase:",
      "options": [
        {
          "label": "A",
          "text": "A and R both are right but R is not the correct explanation of A",
          "correct": false
        },
        {
          "label": "B",
          "text": "A is wrong but R is a right statement",
          "correct": false
        },
        {
          "label": "C",
          "text": "A as well as R are right, and R is a correct explanation of A",
          "correct": true
        },
        {
          "label": "D",
          "text": "A and R both are wrong",
          "correct": false
        }
      ],
      "correct_answer": "C. A as well as R are right, and R is a correct explanation of A",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/10/picture22_WBxHtRE.jpg"
      ],
      "explanation": "<p><strong>Ans. C)</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Acetyl CoA carboxylase is an enzyme crucial in fatty acid synthesis. In a well-fed state, the abundance of acetyl CoA leads to the production of citrate , which can be transported out of the mitochondria into the cytosol .</li><li>\u27a4 Acetyl CoA carboxylase</li><li>\u27a4 fatty acid synthesis.</li><li>\u27a4 well-fed state,</li><li>\u27a4 acetyl CoA</li><li>\u27a4 citrate</li><li>\u27a4 out</li><li>\u27a4 mitochondria into the cytosol</li><li>\u27a4 Citrate serves as an allosteric activator of acetyl CoA carboxylase , increasing its activity. This upregulation is consistent with the body's shift toward anabolic processes , like fatty acid synthesis , when there is a surplus of energy .</li><li>\u27a4 Citrate</li><li>\u27a4 allosteric activator of acetyl CoA carboxylase</li><li>\u27a4 increasing</li><li>\u27a4 activity.</li><li>\u27a4 upregulation</li><li>\u27a4 body's shift toward anabolic processes</li><li>\u27a4 fatty acid synthesis</li><li>\u27a4 surplus of energy</li><li>\u27a4 Ref : Harper 30/e: p 237-238</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e: p 237-238</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "498883ce",
      "audio": ""
    },
    {
      "text": "A research team studying metabolic responses to nutrient deprivation measures enzymatic activities in subjects after a 24-hour fast. They aim to determine which enzyme associated with lipid metabolism shows decreased activity in this energy-conserving state. Which enzyme is the research team least likely to find elevated in the fasting state?",
      "options": [
        {
          "label": "A",
          "text": "CPS\u2013I",
          "correct": false
        },
        {
          "label": "B",
          "text": "Hormone sensitive lipase",
          "correct": false
        },
        {
          "label": "C",
          "text": "Glycogen Phosphorylase",
          "correct": false
        },
        {
          "label": "D",
          "text": "Acetyl CoA carboxylase",
          "correct": true
        }
      ],
      "correct_answer": "D. Acetyl CoA carboxylase",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D)</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 During fasting , the body downregulates enzymes involved in synthesizing storage compounds, such as acetyl CoA carboxylase, while upregulating enzymes that facilitate the mobilization of stored nutrients, like hormone-sensitive lipase and glycogen phosphorylase.</li><li>\u27a4 During fasting</li><li>\u27a4 downregulates</li><li>\u27a4 synthesizing storage</li><li>\u27a4 acetyl CoA carboxylase,</li><li>\u27a4 upregulating enzymes</li><li>\u27a4 facilitate</li><li>\u27a4 stored nutrients,</li><li>\u27a4 hormone-sensitive lipase</li><li>\u27a4 glycogen phosphorylase.</li><li>\u27a4 Ref : Harper 30/e:  p 238</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e:  p 238</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9f99664c",
      "audio": ""
    },
    {
      "text": "Sources of NADPH for fatty acid synthesis include all the following reactions, except:",
      "options": [
        {
          "label": "A",
          "text": "Glucose-6-phosphate dehydrogenase",
          "correct": false
        },
        {
          "label": "B",
          "text": "6-phosphogluconate dehydrogenase",
          "correct": false
        },
        {
          "label": "C",
          "text": "Cytoplasmic malate dehydrogenase",
          "correct": true
        },
        {
          "label": "D",
          "text": "Malic enzyme",
          "correct": false
        }
      ],
      "correct_answer": "C. Cytoplasmic malate dehydrogenase",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: Glucose-6-phosphate dehydrogenase : This enzyme is the first in the pentose phosphate pathway and is a major source of NADPH for fatty acid synthesis by oxidizing glucose-6-phosphate to 6-phosphogluconolactone.</li><li>\u2022 Option A: Glucose-6-phosphate dehydrogenase</li><li>\u2022 first in the pentose phosphate pathway</li><li>\u2022 major source</li><li>\u2022 NADPH for fatty acid synthesis</li><li>\u2022 glucose-6-phosphate to 6-phosphogluconolactone.</li><li>\u2022 Option B: 6-phosphogluconate dehydrogenase : Also part of the pentose phosphate pathway, this enzyme further contributes to NADPH production by oxidizing 6-phosphogluconate to ribulose-5-phosphate.</li><li>\u2022 Option B: 6-phosphogluconate dehydrogenase</li><li>\u2022 pentose phosphate pathway,</li><li>\u2022 NADPH production</li><li>\u2022 6-phosphogluconate to ribulose-5-phosphate.</li><li>\u2022 Option D: Malic enzyme : This enzyme catalyzes the decarboxylation of malate to pyruvate, producing NADPH in the process, and serves as an additional source of NADPH for fatty acid synthesis.</li><li>\u2022 Option D: Malic enzyme</li><li>\u2022 decarboxylation of malate to pyruvate,</li><li>\u2022 NADPH</li><li>\u2022 additional source of NADPH for fatty acid synthesis.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Cytoplasmic malate dehydrogenase is not a source of NADPH for fatty acid synthesis, unlike glucose-6-phosphate dehydrogenase , 6-phosphogluconate dehydrogenase , and the malic enzyme, which all contribute to NADPH production in the cytoplasm for biosynthetic processes such as fatty acid synthesis.</li><li>\u27a4 Cytoplasmic malate dehydrogenase</li><li>\u27a4 not</li><li>\u27a4 NADPH for fatty acid synthesis,</li><li>\u27a4 glucose-6-phosphate dehydrogenase</li><li>\u27a4 6-phosphogluconate dehydrogenase</li><li>\u27a4 malic enzyme,</li><li>\u27a4 NADPH production</li><li>\u27a4 cytoplasm</li><li>\u27a4 biosynthetic</li><li>\u27a4 fatty acid synthesis.</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 159.</li><li>\u27a4 Ref</li><li>\u27a4 : DM Vasudevan 9/e: p 159.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "de682fb8",
      "audio": ""
    }
  ]
}